Human	B-cell_type
renal	I-cell_type
mesangial	I-cell_type
cells	I-cell_type
are	O
a	O
target	O
for	O
the	O
anti-inflammatory	O
action	O
of	O
9-cis	O
retinoic	O
acid	O
.	O

Mesangial	B-cell_type
cells	I-cell_type
play	O
an	O
active	O
role	O
in	O
the	O
inflammatory	O
response	O
to	O
glomerular	O
injury	O
.	O

We	O
have	O
studied	O
in	O
cultured	B-cell_line
human	I-cell_line
mesangial	I-cell_line
cells	I-cell_line
(	O
CHMC	B-cell_line
)	O
several	O
effects	O
of	O
9-cis	O
retinoic	O
acid	O
(	O
9-cRA	O
)	O
,	O
an	O
activator	O
of	O
both	O
retinoic	B-protein
acid	I-protein
receptors	I-protein
(	O
RARs	B-protein
)	O
and	O
retinoid	B-protein
X	I-protein
receptors	I-protein
(	O
RXRs	B-protein
)	O
.	O

9-cRA	O
inhibited	O
foetal	O
calf	O
serum-induced	O
CHMC	B-cell_line
proliferation	O
.	O

It	O
also	O
prevented	O
CHMC	B-cell_line
death	O
induced	O
by	O
the	O
inflammatory	O
mediator	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
.	O

This	O
preventive	O
effect	O
was	O
not	O
due	O
to	O
any	O
increase	O
in	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
catabolism	O
and	O
it	O
persisted	O
even	O
when	O
both	O
catalase	O
and	O
glutathione	O
synthesis	O
were	O
inhibited	O
.	O

Finally	O
,	O
9-cRA	O
diminished	O
monocyte	O
adhesion	O
to	O
FCS-stimulated	B-cell_line
CHMC	I-cell_line
.	O

Interestingly	O
,	O
the	O
retinoid	O
also	O
inhibited	O
in	O
FCS-stimulated	B-cell_type
cells	I-cell_type
the	O
protein	O
expression	O
of	O
two	O
mesangial	B-protein
adhesion	I-protein
molecules	I-protein
,	O
fibronectin	B-protein
and	O
osteopontin	B-protein
,	O
but	O
it	O
did	O
not	O
modify	O
the	O
protein	O
expression	O
of	O
intercellular	B-protein
adhesion	I-protein
molecule-1	I-protein
and	O
vascular	B-protein
adhesion	I-protein
molecule-1	I-protein
.	O

All	O
major	O
RARs	B-protein
and	I-protein
RXRs	I-protein
isotypes	I-protein
were	O
expressed	O
in	O
CHMC	B-cell_line
regardless	O
of	O
the	O
presence	O
or	O
absence	O
of	O
9-cRA	O
.	O

Transcripts	O
to	O
RAR-alpha	B-RNA
,	O
RAR-beta	B-RNA
and	O
RXR-alpha	B-RNA
increased	O
after	O
incubation	O
with	O
9-cRA	O
whereas	O
RXR-gamma	B-RNA
was	O
inhibited	O
,	O
suggesting	O
a	O
major	O
role	O
for	O
RARs	B-protein
and	O
RXRs	B-protein
in	O
9-cRA-anti-inflammatory	O
effects	O
.	O

9-cRA	O
was	O
toxic	O
only	O
at	O
50	O
microM	O
(	O
a	O
concentration	O
50	O
-	O
5000	O
times	O
higher	O
than	O
required	O
for	O
the	O
effects	O
above	O
)	O
.	O

Cell	O
death	O
occurred	O
by	O
apoptosis	O
,	O
whose	O
onset	O
was	O
associated	O
with	O
a	O
pronounced	O
increase	O
in	O
catalase	O
activity	O
and	O
reduced	O
glutathione	O
content	O
,	O
being	O
more	O
effectively	O
induced	O
by	O
all-trans	O
retinoic	O
acid	O
.	O

Modulation	O
of	O
the	O
oxidant/antioxidant	O
balance	O
failed	O
to	O
inhibit	O
apoptosis	O
.	O

We	O
conclude	O
that	O
mesangial	B-cell_type
cells	I-cell_type
might	O
be	O
a	O
target	O
for	O
the	O
treatment	O
of	O
inflammatory	O
glomerulopathies	O
with	O
9-cRA	O
.	O

British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
(	NULL
2000	NULL
)	NULL
131	NULL
,	NULL
1673-1683	NULL
©	NULL
2000	NULL
Macmillan	NULL
Publishers	NULL
Ltd	NULL
All	NULL
rights	NULL
reserved	NULL
0007-1188/00	NULL
$	NULL
15.00	NULL
CB	NULL
www.nature.com/bip	NULL
Human	NULL
renal	NULL
mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
the	NULL
anti-inflammatory	NULL
action	NULL
of	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
+V	NULL
.	NULL

Moreno	NULL
Manzano	NULL
,	NULL
'*J.C.	NULL
Sepulveda	NULL
Munoz	NULL
,	NULL
'	NULL
J	NULL
.	NULL

Rodriguez	NULL
Jiménez	NULL
,	NULL
'M	NULL
.	NULL

Rodriguez	NULL
Puyol	NULL
,	NULL
'D	NULL
.	NULL

Rodriguez	NULL
Puyol	NULL
,	NULL
'M	NULL
.	NULL

Kitamura	NULL
&	NULL
**	NULL
>	NULL
F.J	NULL
.	NULL

Lucio	NULL
Cazana	NULL
'Department	NULL
of	NULL
Physiology	NULL
,	NULL
University	NULL
of	NULL
Alcala	NULL
,	NULL
Alcala	NULL
de	NULL
Henares	NULL
,	NULL
Madrid	NULL
,	NULL
Spain	NULL
;	NULL
Glomerular	NULL
Bioengineering	NULL
Unit	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
College	NULL
Medical	NULL
School	NULL
,	NULL
University	NULL
College	NULL
of	NULL
London	NULL
,	NULL
London	NULL
and	NULL
*Institute	NULL
for	NULL
Peptide	NULL
Research	NULL
,	NULL
Hannover	NULL
,	NULL
Germany	NULL
1	NULL
Mesangial	NULL
cells	NULL
play	NULL
an	NULL
active	NULL
role	NULL
in	NULL
the	NULL
inflammatory	NULL
response	NULL
to	NULL
glomerular	NULL
injury	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
in	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells	NULL
(	NULL
CHMC	NULL
)	NULL
several	NULL
effects	NULL
of	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
9-cRA	NULL
)	NULL
,	NULL
an	NULL
activator	NULL
of	NULL
both	NULL
retinoic	NULL
acid	NULL
receptors	NULL
(	NULL
RARs	NULL
)	NULL
and	NULL
retinoid	NULL
X	NULL
receptors	NULL
(	NULL
RXRs	NULL
)	NULL
.	NULL

2	NULL
9-cRA	NULL
inhibited	NULL
foetal	NULL
calf	NULL
serum-induced	NULL
CHMC	NULL
proliferation	NULL
.	NULL

It	NULL
also	NULL
prevented	NULL
CHMC	NULL
death	NULL
induced	NULL
by	NULL
the	NULL
inflammatory	NULL
mediator	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

This	NULL
preventive	NULL
effect	NULL
was	NULL
not	NULL
due	NULL
to	NULL
any	NULL
increase	NULL
in	NULL
H	NULL
;	NULL
O	NULL
;	NULL
catabolism	NULL
and	NULL
it	NULL
persisted	NULL
even	NULL
when	NULL
both	NULL
catalase	NULL
and	NULL
glutathione	NULL
synthesis	NULL
were	NULL
inhibited	NULL
.	NULL

Finally	NULL
,	NULL
9-cRA	NULL
diminished	NULL
monocyte	NULL
adhesion	NULL
to	NULL
FCS-stimulated	NULL
CHMC	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
retinoid	NULL
also	NULL
inhibited	NULL
in	NULL
FCS-stimulated	NULL
cells	NULL
the	NULL
protein	NULL
expression	NULL
of	NULL
two	NULL
mesangial	NULL
adhesion	NULL
molecules	NULL
,	NULL
fibronectin	NULL
and	NULL
osteopontin	NULL
,	NULL
but	NULL
it	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
protein	NULL
expression	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
vascular	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

3	NULL
All	NULL
major	NULL
RARs	NULL
and	NULL
RXRs	NULL
isotypes	NULL
were	NULL
expressed	NULL
in	NULL
CHMC	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
9-cRA	NULL
.	NULL

Transcripts	NULL
to	NULL
RAR-8	NULL
and	NULL
increased	NULL
after	NULL
incubation	NULL
with	NULL
9-cRA	NULL
whereas	NULL
RXR-y	NULL
was	NULL
inhibited	NULL
,	NULL
suggesting	NULL
a	NULL
major	NULL
role	NULL
for	NULL
RARs	NULL
and	NULL
RXRs	NULL
in	NULL
9-cRA-anti-inflammatory	NULL
effects	NULL
.	NULL

4	NULL
9-cRA	NULL
was	NULL
toxic	NULL
only	NULL
at	NULL
50	NULL
uM	NULL
(	NULL
a	NULL
concentration	NULL
50-5000	NULL
times	NULL
higher	NULL
than	NULL
required	NULL
for	NULL
the	NULL
effects	NULL
above	NULL
)	NULL
.	NULL

Cell	NULL
death	NULL
occurred	NULL
by	NULL
apoptosis	NULL
,	NULL
whose	NULL
onset	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
pronounced	NULL
increase	NULL
in	NULL
catalase	NULL
activity	NULL
and	NULL
reduced	NULL
glutathione	NULL
content	NULL
,	NULL
being	NULL
more	NULL
effectively	NULL
induced	NULL
by	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
.	NULL

Modulation	NULL
of	NULL
the	NULL
oxidant/antioxidant	NULL
balance	NULL
failed	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
.	NULL

5	NULL
We	NULL
conclude	NULL
that	NULL
mesangial	NULL
cells	NULL
might	NULL
be	NULL
a	NULL
target	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
inflammatory	NULL
glomerulopathies	NULL
with	NULL
9-cRA	NULL
.	NULL

British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
(	NULL
2000	NULL
)	NULL
131	NULL
,	NULL
1673-1683	NULL
Mesangial	NULL
cell	NULL
;	NULL
inflammation	NULL
;	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
;	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
;	NULL
monocyte	NULL
;	NULL
osteopontin	NULL
;	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
;	NULL
intercellular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
;	NULL
hydrogen	NULL
peroxide	NULL
;	NULL
apoptosis	NULL
BSO	NULL
,	NULL
L-buthionine-	NULL
(	NULL
S-R	NULL
)	NULL
-sulphoximine	NULL
;	NULL
CHMC	NULL
,	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells	NULL
;	NULL
FCS	NULL
,	NULL
foetal	NULL
calf	NULL
serum	NULL
;	NULL
FN	NULL
,	NULL
GSH	NULL
,	NULL
reduced	NULL
glutathione	NULL
;	NULL
ICAM-1	NULL
,	NULL
lactate	NULL
dehydrogenase	NULL
;	NULL
MTT	NULL
,	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
bromide	NULL
;	NULL
OP	NULL
,	NULL
osteopontin	NULL
;	NULL
RARs	NULL
,	NULL
retinoic	NULL
acid	NULL
receptors	NULL
;	NULL
RXRs	NULL
,	NULL
retinoid	NULL
X	NULL
receptors	NULL
;	NULL
tRA	NULL
,	NULL
all-trans-retinoic	NULL
acid	NULL
;	NULL
VCAM-1	NULL
,	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
;	NULL
9-cRA	NULL
,	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
Keywords	NULL
:	NULL
Abbreviations	NULL
:	NULL
fibronectin	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
intercellular	NULL
molecule	NULL
adhesion-1	NULL
;	NULL
LDH	NULL
,	NULL
Introduction	NULL
Glomerular	NULL
diseases	NULL
remain	NULL
the	NULL
most	NULL
common	NULL
cause	NULL
of	NULL
progressive	NULL
renal	NULL
failure	NULL
that	NULL
may	NULL
require	NULL
dialysis	NULL
or	NULL
kidney	NULL
transplantation	NULL
.	NULL

Remarkable	NULL
recent	NULL
advances	NULL
in	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
pathogenesis	NULL
of	NULL
various	NULL
forms	NULL
of	NULL
glomerulonephritis	NULL
have	NULL
made	NULL
it	NULL
obvious	NULL
that	NULL
glomerular	NULL
cells	NULL
and	NULL
especially	NULL
mesangial	NULL
cells	NULL
play	NULL
an	NULL
active	NULL
part	NULL
in	NULL
the	NULL
inflammatory	NULL
response	NULL
to	NULL
glomerular	NULL
injury	NULL
(	NULL
Pfeilschifter	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
these	NULL
cells	NULL
contribute	NULL
to	NULL
phagocyte	NULL
infiltration	NULL
of	NULL
the	NULL
glomerulus	NULL
during	NULL
glomerular	NULL
inflammation	NULL
since	NULL
they	NULL
express	NULL
cell	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
(	NULL
Denton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Springer	NULL
,	NULL
1994	NULL
,	NULL
Khachigian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
or	NULL
secrete	NULL
osteopontin	NULL
(	NULL
OP	NULL
)	NULL
(	NULL
Nagasaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
a	NULL
glycoprotein	NULL
with	NULL
cell	NULL
adhesive	NULL
properties	NULL
which	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
macrophage	NULL
infiltration	NULL
(	NULL
reviewed	NULL
by	NULL
Giachelli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Lan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
and	NULL
*Author	NULL
for	NULL
correspondence	NULL
at	NULL
:	NULL
Departamento	NULL
de	NULL
Fisiologia	NULL
,	NULL
Facultad	NULL
de	NULL
Medicina	NULL
,	NULL
Universidad	NULL
de	NULL
Alcala	NULL
,	NULL
Alcala	NULL
de	NULL
Henares	NULL
,	NULL
Madrid	NULL
,	NULL
Spain	NULL
.	NULL

E-mail	NULL
:	NULL
javier.Iucio	NULL
@	NULL
uah.es	NULL
*The	NULL
first	NULL
two	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
fibronectin	NULL
(	NULL
FN	NULL
)	NULL
(	NULL
Kosmeh	NULL
!	NULL

I	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
a	NULL
major	NULL
glomerular	NULL
matrix	NULL
component	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
monocyte	NULL
accumulation	NULL
in	NULL
the	NULL
damaged	NULL
kidney	NULL
(	NULL
Chana	NULL
&	NULL
Wheeler	NULL
,	NULL
1999	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
mesangial	NULL
cells	NULL
constitute	NULL
a	NULL
highly	NULL
specialized	NULL
pericapillary	NULL
tissue	NULL
and	NULL
they	NULL
have	NULL
evolved	NULL
three	NULL
prominent	NULL
proinflammatory	NULL
features	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
cross-communication	NULL
with	NULL
invading	NULL
immune	NULL
cells	NULL
(	NULL
Kashgar-ian	NULL
&	NULL
Sterzel	NULL
,	NULL
1992	NULL
)	NULL
;	NULL
(	NULL
1	NULL
)	NULL
increased	NULL
inflammatory	NULL
mediator	NULL
production	NULL
;	NULL
(	NULL
2	NULL
)	NULL
increased	NULL
matrix	NULL
production	NULL
by	NULL
mesangial	NULL
cells	NULL
;	NULL
and	NULL
(	NULL
3	NULL
)	NULL
increased	NULL
mesangial	NULL
cell	NULL
proliferation	NULL
.	NULL

Interestingly	NULL
,	NULL
mesangial	NULL
cells	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
repair	NULL
process	NULL
of	NULL
experimental	NULL
proliferative	NULL
glomerulonephritis	NULL
through	NULL
a	NULL
reduction	NULL
of	NULL
hypercellularity	NULL
by	NULL
means	NULL
of	NULL
the	NULL
process	NULL
of	NULL
apoptosis	NULL
(	NULL
Shimizu	NULL
et	NULL
al	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
that	NULL
all-trans-retinoic	NULL
acid	NULL
(	NULL
tRA	NULL
)	NULL
inhibits	NULL
OP	NULL
mRNA	NULL
expression	NULL
in	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells	NULL
(	NULL
CHMC	NULL
)	NULL
and	NULL
prevents	NULL
the	NULL
cytotoxicity	NULL
of	NULL
H	NULL
;	NULL
O	NULL
,	NULL
-one	NULL
of	NULL
the	NULL
mediators	NULL
implicated	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
inflammatory	NULL
renal	NULL
diseases	NULL
(	NULL
Nath	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
-in	NULL
CHMC	NULL
,	NULL
in	NULL
parallel	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
catalase	NULL
activity	NULL
and	NULL
reduced	NULL
glutathione	NULL
content	NULL
(	NULL
GSH	NULL
)	NULL
.	NULL

There	NULL
is	NULL
now	NULL
1674	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
strong	NULL
evidence	NULL
that	NULL
two	NULL
families	NULL
of	NULL
nuclear	NULL
retinoic	NULL
acid	NULL
receptors	NULL
,	NULL
RAR-z	NULL
,	NULL
-	NULL
#	NULL
,	NULL
-y	NULL
and	NULL
RXR-	NULL
«	NULL
,	NULL
-A	NULL
,	NULL
-y	NULL
mediate	NULL
the	NULL
effects	NULL
of	NULL
retinoids	NULL
(	NULL
reviewed	NULL
by	NULL
Giguere	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

tRA	NULL
only	NULL
activates	NULL
RARs	NULL
whereas	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
9-cRA	NULL
)	NULL
is	NULL
a	NULL
pan-agonist	NULL
and	NULL
it	NULL
activates	NULL
both	NULL
RARs	NULL
and	NULL
RXRs	NULL
(	NULL
Heyman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Levin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Thus	NULL
9-cRA	NULL
may	NULL
lead	NULL
to	NULL
a	NULL
broader	NULL
or	NULL
a	NULL
different	NULL
spectrum	NULL
of	NULL
anti-inflammatory	NULL
activity	NULL
than	NULL
tRA	NULL
.	NULL

Studies	NULL
were	NULL
therefore	NULL
conducted	NULL
to	NULL
explore	NULL
the	NULL
ability	NULL
of	NULL
9-cRA	NULL
:	NULL
(	NULL
1	NULL
)	NULL
to	NULL
modulate	NULL
mesangial	NULL
cell	NULL
number	NULL
through	NULL
antiproliferative	NULL
mechanisms	NULL
;	NULL
(	NULL
2	NULL
)	NULL
to	NULL
inhibit	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
;	NULL
(	NULL
3	NULL
)	NULL
to	NULL
inhibit	NULL
mesangial	NULL
expression	NULL
of	NULL
molecules	NULL
involved	NULL
in	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
;	NULL
and	NULL
(	NULL
4	NULL
)	NULL
to	NULL
prevent	NULL
the	NULL
toxic	NULL
effect	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
on	NULL
CHMC	NULL
,	NULL
which	NULL
may	NULL
be	NULL
secreted	NULL
by	NULL
activated	NULL
macrophages	NULL
(	NULL
Schena	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
gain	NULL
insight	NULL
on	NULL
the	NULL
role	NULL
of	NULL
RARs	NULL
and	NULL
RXRs	NULL
in	NULL
the	NULL
observed	NULL
effects	NULL
,	NULL
we	NULL
also	NULL
studied	NULL
the	NULL
modulatory	NULL
effect	NULL
of	NULL
9-cRA	NULL
on	NULL
mRNA	NULL
expression	NULL
of	NULL
these	NULL
receptors	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
studied	NULL
retinoid	NULL
toxicity	NULL
on	NULL
CHMC	NULL
.	NULL

Methods	NULL
Reagents	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
tRA	NULL
)	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
9-cRA	NULL
)	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Productos	NULL
Roche	NULL
S.A.	NULL
(	NULL
Spain	NULL
)	NULL
.	NULL

Unless	NULL
otherwise	NULL
stated	NULL
,	NULL
all	NULL
of	NULL
the	NULL
biochemical	NULL
reagents	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
Tissue-cultured	NULL
materials	NULL
,	NULL
growth	NULL
media	NULL
and	NULL
serum	NULL
for	NULL
cell	NULL
cultures	NULL
were	NULL
obtained	NULL
from	NULL
Gibco	NULL
Laboratories	NULL
.	NULL

All	NULL
other	NULL
chemicals	NULL
used	NULL
were	NULL
of	NULL
the	NULL
purest	NULL
grade	NULL
commercially	NULL
available	NULL
.	NULL

cDNA	NULL
probes	NULL
and	NULL
antibodies	NULL
VCAM-1	NULL
probe	NULL
was	NULL
a	NULL
HindIII-Xho	NULL
!	NULL

fragment	NULL
of	NULL
the	NULL
human	NULL
cDNA	NULL
consisting	NULL
of	NULL
nucleotides	NULL
132-1814	NULL
(	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
OP	NULL
probe	NULL
was	NULL
a	NULL
1.4	NULL
kb	NULL
BamHI-HindIII	NULL
fragment	NULL
of	NULL
the	NULL
rat	NULL
OP	NULL
cDNA	NULL
(	NULL
Giachelli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
ICAM-1	NULL
probe	NULL
was	NULL
a	NULL
1.8	NULL
kb	NULL
Sall-Kpnl	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
cDNA	NULL
(	NULL
Stauton	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
FN	NULL
probe	NULL
was	NULL
a	NULL
Aval-HindIlI	NULL
fragment	NULL
consisting	NULL
of	NULL
649	NULL
nucleotides	NULL
of	NULL
the	NULL
human	NULL
FN	NULL
(	NULL
Meyers	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
following	NULL
probes	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Pierre	NULL
Chambon	NULL
(	NULL
Institut	NULL
de	NULL
Genetique	NULL
et	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
et	NULL
Cellulaire	NULL
,	NULL
Strasbourg	NULL
,	NULL
France	NULL
)	NULL
were	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
RARs	NULL
and	NULL
RXRs	NULL
:	NULL
RAR-z	NULL
probe	NULL
was	NULL
a	NULL
1.7	NULL
kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
RAR-z	NULL
cDNA	NULL
(	NULL
Petkovich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
;	NULL
RAR-§	NULL
probe	NULL
was	NULL
a	NULL
1.5	NULL
kb	NULL
BamHI-Sacl	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
RAR-8	NULL
cDNA	NULL
(	NULL
Brand	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
;	NULL
RAR-y	NULL
probe	NULL
was	NULL
a	NULL
1.5	NULL
kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
RAR-y	NULL
cDNA	NULL
(	NULL
Krust	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
;	NULL
RXR-z	NULL
probe	NULL
was	NULL
a	NULL
1.4	NULL
kb	NULL
Xbal-Xho	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
RXR-z	NULL
cDNA	NULL
(	NULL
Leid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
;	NULL
RXR-	NULL
#	NULL
probe	NULL
was	NULL
a	NULL
1.8	NULL
kb	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
RXR-	NULL
$	NULL
cDNA	NULL
(	NULL
Leid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
RXR-y	NULL
probe	NULL
was	NULL
a	NULL
2.0	NULL
kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
RXR-y	NULL
cDNA	NULL
(	NULL
Leid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Four	NULL
different	NULL
primary	NULL
antibodies	NULL
were	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
:	NULL
(	NULL
1	NULL
)	NULL
Monoclonal	NULL
mouse	NULL
antibody	NULL
anti-human	NULL
VCAM-1	NULL
(	NULL
catalogue	NULL
no	NULL
.	NULL

BBA5S	NULL
,	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
;	NULL
(	NULL
2	NULL
)	NULL
Monoclonal	NULL
mouse	NULL
antibody	NULL
anti-human	NULL
ICAM-1	NULL
(	NULL
catalogue	NULL
no	NULL
.	NULL

BBA3	NULL
,	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
;	NULL
(	NULL
3	NULL
)	NULL
Polyclonal	NULL
rabbit	NULL
antibody	NULL
anti-human	NULL
OP	NULL
(	NULL
catalogue	NULL
no	NULL
.	NULL

AB1870	NULL
,	NULL
Chemicon	NULL
)	NULL
;	NULL
and	NULL
(	NULL
4	NULL
)	NULL
Monoclonal	NULL
mouse	NULL
antibody	NULL
anti-human	NULL
fibronectin	NULL
cell	NULL
binding	NULL
domain	NULL
(	NULL
catalogue	NULL
no	NULL
.	NULL

MAB1937	NULL
,	NULL
Chemicon	NULL
)	NULL
.	NULL

Secondary	NULL
antibodies	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
were	NULL
either	NULL
anti-mouse	NULL
IgG-against	NULL
primary	NULL
monoclonal	NULL
antibodies-	NULL
(	NULL
catalogue	NULL
no	NULL
.	NULL

A4416	NULL
,	NULL
Sigma	NULL
)	NULL
or	NULL
anti-rabbit	NULL
IgG-against	NULL
the	NULL
primary	NULL
polyclonal	NULL
antibody	NULL
-	NULL
(	NULL
catalogue	NULL
no	NULL
.	NULL

AP132P	NULL
,	NULL
Chemicon	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
Human	NULL
mesangial	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
adult	NULL
specimens	NULL
,	NULL
as	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
(	NULL
Diez	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
confirmed	NULL
by	NULL
morphologic	NULL
and	NULL
functional	NULL
criteria	NULL
.	NULL

Under	NULL
phase-contrast	NULL
microscopy	NULL
all	NULL
the	NULL
cells	NULL
appeared	NULL
large	NULL
and	NULL
stellate	NULL
and	NULL
no	NULL
cells	NULL
with	NULL
epithelial	NULL
or	NULL
endothelial	NULL
morphologic	NULL
characteristics	NULL
were	NULL
seen	NULL
.	NULL

Mesangial	NULL
cells	NULL
showed	NULL
histochemical	NULL
evidence	NULL
of	NULL
containing	NULL
actomyosin	NULL
fibres	NULL
,	NULL
and	NULL
they	NULL
did	NULL
not	NULL
stain	NULL
for	NULL
factor	NULL
VIII	NULL
,	NULL
unlike	NULL
endothelial	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
all	NULL
the	NULL
cells	NULL
examined	NULL
contracted	NULL
after	NULL
incubation	NULL
with	NULL
platelet	NULL
activating	NULL
factor	NULL
,	NULL
angiotensin	NULL
II	NULL
and	NULL
arginine-vasopressin	NULL
.	NULL

Cultured	NULL
medium	NULL
was	NULL
made	NULL
of	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
foetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
200	NULL
mm	NULL
L-glutamine	NULL
and	NULL
antibiotics	NULL
(	NULL
penicillin	NULL
100	NULL
u	NULL
ml-	NULL
'	NULL
,	NULL
streptomycin	NULL
100	NULL
ug	NULL
ml-	NULL
'	NULL
and	NULL
amphotericin	NULL
B	NULL
0.25	NULL
ug	NULL
ml-	NULL
'	NULL
)	NULL
.	NULL

Confluent	NULL
cells	NULL
between	NULL
12th	NULL
and	NULL
15th	NULL
passages	NULL
were	NULL
used	NULL
and	NULL
they	NULL
were	NULL
made	NULL
quiescent	NULL
when	NULL
appropriate	NULL
by	NULL
48	NULL
h	NULL
incubation	NULL
with	NULL
medium	NULL
supplemented	NULL
with	NULL
0.5	NULL
%	NULL
FCS	NULL
.	NULL

Experimental	NULL
design	NULL
9-cRA	NULL
was	NULL
dissolved	NULL
in	NULL
ethanol	NULL
and	NULL
appropriate	NULL
controls	NULL
consisting	NULL
of	NULL
either	NULL
vehicle	NULL
(	NULL
final	NULL
concentration	NULL
0.09	NULL
%	NULL
)	NULL
or	NULL
medium	NULL
were	NULL
always	NULL
included	NULL
(	NULL
when	NULL
necessary	NULL
,	NULL
retinoid	NULL
effects	NULL
were	NULL
first	NULL
tested	NULL
in	NULL
dose-response	NULL
and	NULL
time-response	NULL
experiments	NULL
(	NULL
in	NULL
some	NULL
experiments	NULL
tRA	NULL
effects	NULL
were	NULL
also	NULL
tested	NULL
)	NULL
)	NULL
.	NULL

Studies	NULL
performed	NULL
were	NULL
:	NULL
(	NULL
1	NULL
)	NULL
Modulation	NULL
of	NULL
cell	NULL
number	NULL
.	NULL

We	NULL
assessed	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
9-cRA	NULL
on	NULL
FCS-stimulated	NULL
mesangial	NULL
cell	NULL
proliferation	NULL
by	NULL
three	NULL
different	NULL
methods	NULL
:	NULL
direct	NULL
cell	NULL
count	NULL
,	NULL
[	NULL
PH	NULL
]	NULL
-thymidine	NULL
incorporation	NULL
and	NULL
reduction	NULL
of	NULL
3-	NULL
(	NULL
4	NULL
,	NULL
5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
_	NULL
bromide	NULL
(	NULL
MTT	NULL
)	NULL
.	NULL

We	NULL
also	NULL
studied	NULL
retinoid	NULL
toxicity	NULL
.	NULL

These	NULL
later	NULL
studies	NULL
were	NULL
mainly	NULL
performed	NULL
with	NULL
tRA	NULL
(	NULL
since	NULL
it	NULL
was	NULL
a	NULL
stronger	NULL
inducer	NULL
of	NULL
apoptosis	NULL
than	NULL
9-cRA	NULL
)	NULL
and	NULL
they	NULL
consisted	NULL
of	NULL
assessment	NULL
of	NULL
the	NULL
loss	NULL
of	NULL
viable	NULL
cells	NULL
,	NULL
identification	NULL
of	NULL
apoptotic	NULL
death	NULL
and	NULL
changes	NULL
in	NULL
antioxidant	NULL
defence	NULL
systems	NULL
such	NULL
as	NULL
catalase	NULL
activity	NULL
and	NULL
reduced	NULL
glutathione	NULL
content	NULL
;	NULL
(	NULL
2	NULL
)	NULL
Prevention	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-induced	NULL
cell	NULL
death	NULL
.	NULL

Quiescent	NULL
CHMC	NULL
in	NULL
96-well	NULL
plates	NULL
(	NULL
typically	NULL
20,000	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
were	NULL
preincubated	NULL
either	NULL
with	NULL
9-cRA	NULL
or	NULL
tRA	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
H	NULL
;	NULL
O	NULL
;	NULL
for	NULL
24	NULL
h.	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
-induced	NULL
cytotoxicity	NULL
was	NULL
quantified	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
,	NULL
by	NULL
measuring	NULL
LDH	NULL
efflux	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
the	NULL
damaged	NULL
cells	NULL
.	NULL

Since	NULL
tRA	NULL
stimulates	NULL
antioxidant	NULL
defences	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
,	NULL
additional	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
potency	NULL
of	NULL
tRA	NULL
and	NULL
9-cRA	NULL
in	NULL
terms	NULL
of	NULL
maximal	NULL
stimulation	NULL
of	NULL
the	NULL
GSH	NULL
system	NULL
and	NULL
to	NULL
confirm	NULL
if	NULL
prevention	NULL
was	NULL
really	NULL
due	NULL
to	NULL
increased	NULL
H	NULL
;	NULL
O	NULL
,	NULL
catabolism	NULL
(	NULL
by	NULL
measuring	NULL
the	NULL
rate	NULL
of	NULL
comsuption	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
exogenously	NULL
added	NULL
to	NULL
CHMC	NULL
preincubated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
the	NULL
either	NULL
9-cRA	NULL
or	NULL
tRA	NULL
)	NULL
;	NULL
(	NULL
3	NULL
)	NULL
Inhibition	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
.	NULL

Experiments	NULL
to	NULL
study	NULL
the	NULL
inhibition	NULL
by	NULL
9-cRA	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
stimulated	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
:	NULL
confluent	NULL
CHMC	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
20	NULL
%	NULL
FCS	NULL
containing	NULL
9-cRA	NULL
or	NULL
vehicle	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
human	NULL
monocytes	NULL
,	NULL
isolated	NULL
from	NULL
blood	NULL
from	NULL
healthy	NULL
donors	NULL
,	NULL
were	NULL
added	NULL
to	NULL
CHMC	NULL
.	NULL

After	NULL
coincubation	NULL
for	NULL
2	NULL
h	NULL
,	NULL
the	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
CHMC	NULL
was	NULL
quantified	NULL
as	NULL
described	NULL
below	NULL
;	NULL
(	NULL
4	NULL
)	NULL
Inhibition	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
FN	NULL
,	NULL
OP	NULL
,	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
.	NULL

Experiments	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
above	NULL
were	NULL
performed	NULL
.	NULL

At	NULL
definite	NULL
time	NULL
intervals	NULL
along	NULL
the	NULL
incubation	NULL
period	NULL
with	NULL
9-cRA	NULL
,	NULL
total	NULL
RNA	NULL
or	NULL
protein	NULL
was	NULL
extracted	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
mentioned	NULL
molecules	NULL
was	NULL
assessed	NULL
by	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
techniques	NULL
;	NULL
(	NULL
5	NULL
)	NULL
Expression	NULL
of	NULL
mRNA	NULL
for	NULL
RARs	NULL
and	NULL
RXRs	NULL
in	NULL
mesangial	NULL
cells	NULL
and	NULL
its	NULL
modulation	NULL
by	NULL
9-cRA	NULL
.	NULL

Retinoid	NULL
effects	NULL
were	NULL
tested	NULL
in	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
1675	NULL
time-response	NULL
experiments	NULL
,	NULL
using	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
uM	NULL
to	NULL
ensure	NULL
a	NULL
maximal	NULL
response	NULL
.	NULL

At	NULL
definite	NULL
time	NULL
intervals	NULL
along	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
the	NULL
mentioned	NULL
molecules	NULL
was	NULL
assessed	NULL
by	NULL
Northern	NULL
blot	NULL
techniques	NULL
.	NULL

Analytic	NULL
procedures	NULL
Measurement	NULL
of	NULL
cell	NULL
proliferation	NULL
-	NULL
Cells	NULL
at	NULL
~80	NULL
%	NULL
confluence	NULL
in	NULL
96-well	NULL
plates	NULL
(	NULL
MTT	NULL
assay	NULL
)	NULL
or	NULL
in	NULL
24-well	NULL
plates	NULL
(	NULL
PH	NULL
]	NULL
-thymidine	NULL
incorporation	NULL
)	NULL
or	NULL
in	NULL
6-well	NULL
plates	NULL
(	NULL
direct	NULL
cell	NULL
count	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
+0.5	NULL
%	NULL
FCS	NULL
for	NULL
48	NULL
h	NULL
to	NULL
induce	NULL
quiescence	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
preincubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
the	NULL
retinoids	NULL
,	NULL
and	NULL
then	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
for	NULL
24	NULL
h.	NULL
Monolayers	NULL
were	NULL
then	NULL
tested	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
reduce	NULL
exogenous	NULL
__	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphenyltetrazo-lium	NULL
bromide	NULL
(	NULL
MTT	NULL
)	NULL
to	NULL
formazan	NULL
(	NULL
McGahon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
or	NULL
to	NULL
incorporate	NULL
[	NULL
PH	NULL
]	NULL
-thymidine	NULL
.	NULL

Each	NULL
experimental	NULL
condition	NULL
was	NULL
assayed	NULL
in	NULL
quadruplicate	NULL
.	NULL

The	NULL
MTT	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
cells	NULL
incubated	NULL
for	NULL
6h	NULL
with	NULL
MTT	NULL
(	NULL
0.15	NULL
ug	NULL
ml-	NULL
'	NULL
)	NULL
.	NULL

The	NULL
blue	NULL
formazan	NULL
product	NULL
was	NULL
solubilized	NULL
with	NULL
0.04	NULL
m	NULL
HCl	NULL
in	NULL
isopropanol	NULL
and	NULL
the	NULL
plates	NULL
were	NULL
then	NULL
read	NULL
on	NULL
a	NULL
microELISA	NULL
reader	NULL
using	NULL
a	NULL
test	NULL
wavelength	NULL
of	NULL
595	NULL
nm	NULL
(	NULL
McGahon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
treated	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
[	NULL
PH	NULL
]	NULL
-thymidine	NULL
(	NULL
1	NULL
4Ci	NULL
well~	NULL
!	NULL

,	NULL
10	NULL
Ci	NULL
mmol~	NULL
'	NULL
,	NULL
American	NULL
Radiolabeled	NULL
Chemicals	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
,	NULL
U.S.A.	NULL
)	NULL
and	NULL
,	NULL
after	NULL
removing	NULL
medium	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Then	NULL
ice-cold	NULL
10	NULL
%	NULL
trichloroacetic	NULL
acid	NULL
was	NULL
added	NULL
to	NULL
remove	NULL
acid-soluble	NULL
materials	NULL
and	NULL
,	NULL
5	NULL
min	NULL
later	NULL
,	NULL
it	NULL
was	NULL
removed	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
solubilized	NULL
overnight	NULL
in	NULL
0.1	NULL
m	NULL
NaOH	NULL
and	NULL
subjected	NULL
to	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Finally	NULL
,	NULL
direct	NULL
cell	NULL
counting	NULL
was	NULL
performed	NULL
on	NULL
trypsinized	NULL
cells	NULL
from	NULL
6-well	NULL
plates	NULL
,	NULL
non-viable	NULL
cells	NULL
(	NULL
Trypan	NULL
blue	NULL
analysis	NULL
)	NULL
were	NULL
excluded	NULL
from	NULL
the	NULL
count	NULL
.	NULL

Apoptosis	NULL
assays	NULL
(	NULL
1	NULL
)	NULL
Microscopic	NULL
analyses	NULL
;	NULL
Morphologic	NULL
examination	NULL
was	NULL
performed	NULL
by	NULL
light	NULL
and	NULL
fluorescent	NULL
micro-scopy	NULL
.	NULL

Cells	NULL
for	NULL
light	NULL
microscopy	NULL
were	NULL
fixed	NULL
using	NULL
10	NULL
%	NULL
buffered	NULL
formaline	NULL
and	NULL
stained	NULL
for	NULL
60	NULL
min	NULL
with	NULL
Giemsa	NULL
reagent	NULL
.	NULL

Cells	NULL
were	NULL
also	NULL
examined	NULL
under	NULL
fluorescent	NULL
micro-scopy	NULL
,	NULL
after	NULL
staining	NULL
with	NULL
acridine	NULL
orange	NULL
(	NULL
4	NULL
ug	NULL
ml-	NULL
'	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Apoptosis	NULL
was	NULL
identified	NULL
using	NULL
morphological	NULL
criteria	NULL
including	NULL
pycnotic	NULL
nuclei	NULL
,	NULL
marked	NULL
chromatin	NULL
condensation	NULL
,	NULL
nuclear	NULL
fragmentation	NULL
into	NULL
spherical	NULL
structures	NULL
,	NULL
and	NULL
apoptotic	NULL
bodies	NULL
.	NULL

We	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
mesangial	NULL
cells	NULL
cultured	NULL
without	NULL
foetal	NULL
calf	NULL
serum	NULL
for	NULL
6	NULL
days	NULL
,	NULL
and	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
mesangial	NULL
cells	NULL
cultured	NULL
with	NULL
15	NULL
%	NULL
of	NULL
foetal	NULL
calf	NULL
serum	NULL
.	NULL

(	NULL
2	NULL
)	NULL
In	NULL
situ	NULL
detection	NULL
of	NULL
apoptosis	NULL
:	NULL
Mesangial	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
fixed	NULL
during	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
4	NULL
%	NULL
formaldehyde	NULL
containing	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Then	NULL
,	NULL
in	NULL
situ	NULL
end	NULL
labelling	NULL
(	NULL
TUNEL	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
the	NULL
In	NULL
situ	NULL
cell	NULL
death	NULL
detection	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

(	NULL
3	NULL
)	NULL
Trypan	NULL
blue	NULL
analysis	NULL
:	NULL
Cells	NULL
were	NULL
trypsinized	NULL
,	NULL
stained	NULL
with	NULL
trypan	NULL
blue	NULL
dye	NULL
and	NULL
total	NULL
cell	NULL
count	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
Neubauer	NULL
chamber	NULL
.	NULL

Assays	NULL
were	NULL
repeated	NULL
four	NULL
times	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Measurement	NULL
of	NULL
antioxidant	NULL
defences	NULL
:	NULL
(	NULL
i	NULL
)	NULL
Catalase	NULL
activity	NULL
(	NULL
Aebi	NULL
,	NULL
1983	NULL
)	NULL
:	NULL
Sample	NULL
was	NULL
diluted	NULL
in	NULL
phosphate	NULL
buffer	NULL
(	NULL
KH	NULL
;	NULL
PO4	NULL
50	NULL
mm	NULL
,	NULL
pH	NULL
7.0	NULL
)	NULL
containing	NULL
0.2	NULL
%	NULL
Triton-X-100	NULL
and	NULL
2	NULL
ml	NULL
were	NULL
added	NULL
to	NULL
1	NULL
ml	NULL
of	NULL
30	NULL
mM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

Changes	NULL
in	NULL
absorbance	NULL
at	NULL
240	NULL
nm	NULL
were	NULL
measured	NULL
for	NULL
30	NULL
s.	NULL
The	NULL
rate	NULL
constant	NULL
of	NULL
a	NULL
first-order	NULL
reaction	NULL
(	NULL
k	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
unit	NULL
by	NULL
the	NULL
equation	NULL
k=	NULL
(	NULL
1/p	NULL
-	NULL
4	NULL
)	NULL
x	NULL
In	NULL
(	NULL
A1/Ag	NULL
)	NULL
,	NULL
(	NULL
1	NULL
)	NULL
where	NULL
1	NULL
;	NULL
-t	NULL
;	NULL
is	NULL
the	NULL
measured	NULL
interval	NULL
in	NULL
seconds	NULL
and	NULL
A	NULL
;	NULL
and	NULL
A	NULL
,	NULL
are	NULL
the	NULL
absorbances	NULL
at	NULL
initial	NULL
and	NULL
final	NULL
measurement	NULL
points	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
were	NULL
corrected	NULL
to	NULL
cellular	NULL
protein	NULL
content	NULL
(	NULL
Lowry	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1951	NULL
)	NULL
:	NULL
(	NULL
ii	NULL
)	NULL
Reduced	NULL
glutathione	NULL
content	NULL
:	NULL
Cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
cold	NULL
room	NULL
and	NULL
proteins	NULL
were	NULL
precipitated	NULL
with	NULL
0.9	NULL
ml	NULL
perchloric	NULL
acid	NULL
.	NULL

After	NULL
neutralization	NULL
with	NULL
0.3	NULL
ml	NULL
1	NULL
M	NULL
KOH/KHCO	NULL
;	NULL
and	NULL
centrifugation	NULL
,	NULL
0.15	NULL
ml	NULL
of	NULL
supernatant	NULL
were	NULL
collected	NULL
on	NULL
plastic	NULL
tubes	NULL
,	NULL
o-phtal-dialde-hyde	NULL
was	NULL
added	NULL
(	NULL
0.15	NULL
ml	NULL
of	NULL
a	NULL
7.46	NULL
um	NULL
solution	NULL
)	NULL
and	NULL
tubes	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

GSH	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
scanning	NULL
fluorescence	NULL
spectrophotometer	NULL
(	NULL
Perkin-Elmer	NULL
model	NULL
LS-5B	NULL
)	NULL
at	NULL
420	NULL
nm	NULL
with	NULL
excitation	NULL
wavelength	NULL
of	NULL
350	NULL
nm	NULL
,	NULL
using	NULL
a	NULL
standard	NULL
curve	NULL
(	NULL
Hissin	NULL
&	NULL
Hilf	NULL
,	NULL
1976	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
corrected	NULL
for	NULL
cellular	NULL
protein	NULL
.	NULL

H	NULL
;	NULL
,0	NULL
;	NULL
-induced	NULL
cytotoxicity	NULL
The	NULL
cytotoxicity	NULL
detection	NULL
kit	NULL
(	NULL
LDH	NULL
)	NULL
(	NULL
supplied	NULL
by	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
was	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Each	NULL
experimental	NULL
condition	NULL
was	NULL
assayed	NULL
in	NULL
quadruplicate	NULL
.	NULL

H	NULL
,	NULL
O	NULL
;	NULL
assay	NULL
Consumption	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
horseradish	NULL
peroxidase-mediated	NULL
oxidation	NULL
of	NULL
phenol	NULL
red	NULL
(	NULL
Pick	NULL
&	NULL
Keisari	NULL
,	NULL
1980	NULL
)	NULL
,	NULL
as	NULL
described	NULL
for	NULL
renal	NULL
tissue	NULL
(	NULL
Ricardo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
;	NULL
H	NULL
;	NULL
O	NULL
;	NULL
(	NULL
100	NULL
um	NULL
final	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
to	NULL
CHMC	NULL
and	NULL
,	NULL
at	NULL
the	NULL
appropriate	NULL
times	NULL
,	NULL
40	NULL
ul	NULL
of	NULL
medium	NULL
were	NULL
removed	NULL
and	NULL
added	NULL
to	NULL
1.12	NULL
ml	NULL
of	NULL
the	NULL
phenol	NULL
red	NULL
solution	NULL
(	NULL
0.1	NULL
g	NULL
phenol	NULL
red	NULL
I-	NULL
'	NULL
)	NULL
,	NULL
140	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
mm	NULL
potassium	NULL
phosphate	NULL
buffer	NULL
and	NULL
5.5	NULL
mm	NULL
dextrose	NULL
)	NULL
with	NULL
40	NULL
ul	NULL
of	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
1.5	NULL
g/l	NULL
)	NULL
.	NULL

The	NULL
cuvettes	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
brought	NULL
to	NULL
pH	NULL
12.5	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
72	NULL
ul	NULL
of	NULL
1	NULL
N	NULL
NaOH	NULL
.	NULL

Absorbance	NULL
was	NULL
read	NULL
at	NULL
610	NULL
nm	NULL
against	NULL
an	NULL
H	NULL
;	NULL
O	NULL
»	NULL
-standard	NULL
curve	NULL
(	NULL
Ricardo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Human	NULL
monocyte	NULL
isolation	NULL
and	NULL
adhesion	NULL
assays	NULL
Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
25	NULL
ml	NULL
heparinized	NULL
blood	NULL
from	NULL
healthy	NULL
donors	NULL
(	NULL
Heidenreich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
mono-nuclear	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
(	NULL
400	NULL
x	NULL
g	NULL
,	NULL
30	NULL
min	NULL
)	NULL
,	NULL
washed	NULL
and	NULL
seeded	NULL
on	NULL
plastic	NULL
culture	NULL
plates	NULL
(	NULL
Falcon	NULL
,	NULL
U.S.A.	NULL
)	NULL
containing	NULL
RPMI1640	NULL
medium	NULL
and	NULL
20	NULL
%	NULL
FCS	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
/95	NULL
%	NULL
air	NULL
atmosphere	NULL
in	NULL
order	NULL
to	NULL
enrich	NULL
the	NULL
sample	NULL
in	NULL
monocytes	NULL
by	NULL
1	NULL
h	NULL
adherence	NULL
to	NULL
culture	NULL
plates	NULL
(	NULL
Heidenreich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

This	NULL
procedure	NULL
gave	NULL
a	NULL
purity	NULL
>	NULL
90	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
CD14	NULL
antibodies	NULL
as	NULL
an	NULL
specific	NULL
monocyte-macrophage	NULL
marker	NULL
(	NULL
Passlick	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
and	NULL
a	NULL
viability	NULL
>	NULL
95	NULL
%	NULL
as	NULL
detected	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
was	NULL
tested	NULL
by	NULL
a	NULL
previously	NULL
described	NULL
method	NULL
(	NULL
Shih	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
to	NULL
study	NULL
monocyte/endothelial	NULL
interactions	NULL
,	NULL
with	NULL
several	NULL
modifica-tions	NULL
.	NULL

Enriched	NULL
monocytes	NULL
(	NULL
800,000	NULL
ml-	NULL
'	NULL
)	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
medium	NULL
were	NULL
layered	NULL
onto	NULL
confluent	NULL
monolayers	NULL
of	NULL
CHMC	NULL
in	NULL
35	NULL
mm	NULL
Petri	NULL
plates	NULL
(	NULL
total	NULL
volume	NULL
:	NULL
400	NULL
ul	NULL
per	NULL
plate	NULL
)	NULL
and	NULL
cells	NULL
were	NULL
co-incubated	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h	NULL
(	NULL
this	NULL
time	NULL
was	NULL
chosen	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
preliminary	NULL
time-course	NULL
experiments	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
then	NULL
aspi-rated	NULL
,	NULL
and	NULL
non-adherent	NULL
monocytes	NULL
were	NULL
dislodged	NULL
by	NULL
gently	NULL
rinsing	NULL
the	NULL
monolayers	NULL
three	NULL
times	NULL
with	NULL
sterile	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
with	NULL
methanol/ethanol	NULL
1:1	NULL
(	NULL
v	NULL
v-	NULL
'	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
Giemsa	NULL
during	NULL
3	NULL
h.	NULL
These	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
plates	NULL
for	NULL
every	NULL
experimental	NULL
condition	NULL
.	NULL

Under	NULL
light	NULL
microscopy	NULL
(	NULL
x	NULL
100	NULL
)	NULL
,	NULL
CHMC	NULL
grew	NULL
in	NULL
monolayers	NULL
and	NULL
showed	NULL
a	NULL
-	NULL
characteristic	NULL
-	NULL
stellate	NULL
appearance	NULL
with	NULL
smooth	NULL
peripheral	NULL
borders	NULL
,	NULL
whereas	NULL
monocytes	NULL
exhibited	NULL
a	NULL
round	NULL
profile	NULL
,	NULL
with	NULL
little	NULL
presence	NULL
of	NULL
cytoplasm	NULL
and	NULL
a	NULL
pycnotic	NULL
nucleus	NULL
,	NULL
and	NULL
a	NULL
cell	NULL
size	NULL
around	NULL
3-5	NULL
times	NULL
smaller	NULL
than	NULL
CHMC	NULL
.	NULL

Identification	NULL
of	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
1676	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
these	NULL
cells	NULL
as	NULL
monocytes	NULL
was	NULL
confirmed	NULL
by	NULL
staining	NULL
for	NULL
nonspecific	NULL
esterase	NULL
.	NULL

Counts	NULL
of	NULL
adherent	NULL
monocytes	NULL
was	NULL
performed	NULL
by	NULL
three	NULL
independent	NULL
observers	NULL
in	NULL
a	NULL
double-blind	NULL
fashion	NULL
(	NULL
every	NULL
observer	NULL
selected	NULL
in	NULL
a	NULL
random	NULL
way	NULL
10	NULL
microscopic	NULL
fields	NULL
in	NULL
every	NULL
plate	NULL
)	NULL
.	NULL

Northern	NULL
blots	NULL
mRNA	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
total	NULL
RNA	NULL
extracts	NULL
isolated	NULL
from	NULL
CHMC	NULL
(	NULL
Chomezynsky	NULL
&	NULL
Sacchi	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
denaturing	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
and	NULL
probed	NULL
with	NULL
[	NULL
°P	NULL
]	NULL
-labeled-probes	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
at	NULL
room	NULL
temperature	NULL
twice	NULL
with	NULL
2x	NULL
standard	NULL
saline	NULL
citrate	NULL
(	NULL
1x	NULL
standard	NULL
saline	NULL
citrate	NULL
:	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
0.015	NULL
M	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
at	NULL
65°C	NULL
twice	NULL
with	NULL
1x	NULL
standard	NULL
saline	NULL
citrate	NULL
containing	NULL
1	NULL
%	NULL
sodium	NULL
dodecylsulfate	NULL
and	NULL
at	NULL
65°C	NULL
twice	NULL
with	NULL
0.1	NULL
x	NULL
standard	NULL
saline	NULL
citrate	NULL
containing	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulphate	NULL
.	NULL

As	NULL
a	NULL
loading	NULL
control	NULL
,	NULL
blots	NULL
were	NULL
also	NULL
probed	NULL
with	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
expression	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
(	NULL
Kodak	NULL
,	NULL
XOMAT	NULL
)	NULL
or	NULL
visualized	NULL
in	NULL
a	NULL
Phosphorimager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Western	NULL
blots	NULL
Mesangial	NULL
cells	NULL
were	NULL
solubilized	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
detergents	NULL
and	NULL
protease	NULL
inhibitors	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Shih	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
before	NULL
being	NULL
separated	NULL
on	NULL
a	NULL
5-10	NULL
%	NULL
SDS-PAGE	NULL
;	NULL
then	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
antibodies	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1-2	NULL
ug	NULL
ml-	NULL
'	NULL
.	NULL

Blots	NULL
were	NULL
developed	NULL
using	NULL
secondary	NULL
antibodies	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
for	NULL
viewing	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Statistics	NULL
Data	NULL
were	NULL
compared	NULL
using	NULL
Student	NULL
's	NULL
t-test	NULL
,	NULL
and	NULL
P	NULL
<	NULL
0.05	NULL
was	NULL
considered	NULL
statistically	NULL
significant	NULL
.	NULL

When	NULL
multiple	NULL
mean	NULL
values	NULL
were	NULL
involved	NULL
,	NULL
an	NULL
ANOVA	NULL
was	NULL
first	NULL
performed	NULL
followed	NULL
by	NULL
post	NULL
hoe	NULL
comparisons	NULL
performed	NULL
with	NULL
a	NULL
Bonferroni/Dunn	NULL
test	NULL
.	NULL

Results	NULL
Inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
retinoid	NULL
toxicity	NULL
Inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
We	NULL
asked	NULL
if	NULL
9-cRA	NULL
would	NULL
inhibit	NULL
CHMC	NULL
proliferation	NULL
.	NULL

We	NULL
therefore	NULL
added	NULL
20	NULL
%	NULL
FCS	NULL
to	NULL
quiescent	NULL
CHMC	NULL
preincubated	NULL
or	NULL
not	NULL
with	NULL
9-cRA	NULL
.	NULL

FCS	NULL
added	NULL
alone	NULL
stimulated	NULL
a	NULL
15-18	NULL
%	NULL
increase	NULL
in	NULL
MTT	NULL
reduction	NULL
and	NULL
cell	NULL
count	NULL
increased	NULL
from	NULL
335,209	NULL
+18,204	NULL
cells	NULL
per	NULL
well	NULL
to	NULL
381,204	NULL
+23,326	NULL
cells	NULL
per	NULL
well	NULL
(	NULL
n=3	NULL
)	NULL
.	NULL

9-cRA	NULL
caused	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
MTT	NULL
reduction	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
within	NULL
a	NULL
narrow	NULL
dose	NULL
range	NULL
:	NULL
threshold	NULL
inhibition	NULL
was	NULL
found	NULL
at	NULL
10	NULL
nM	NULL
9-cRA	NULL
and	NULL
maximal	NULL
inhibition	NULL
of	NULL
FCS-stimulated	NULL
MTT	NULL
reduction	NULL
occurred	NULL
at	NULL
100	NULL
nM	NULL
9-cRA	NULL
(	NULL
cell	NULL
count	NULL
was	NULL
346,207	NULL
+21,409	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
way	NULL
,	NULL
maximal	NULL
inhibition	NULL
of	NULL
FCS-stimulated	NULL
incorporation	NULL
occurred	NULL
at	NULL
100	NULL
nm	NULL
9-cRA	NULL
(	NULL
the	NULL
per	NULL
cent	NULL
of	NULL
inhibition	NULL
was	NULL
61+5	NULL
,	NULL
n=3	NULL
)	NULL
Maximal	NULL
inhibition	NULL
by	NULL
tRA	NULL
(	NULL
the	NULL
per	NULL
cent	NULL
of	NULL
inhibition	NULL
was	NULL
69+8	NULL
,	NULL
n	NULL
»	NULL
=3	NULL
)	NULL
was	NULL
of	NULL
similar	NULL
magnitude	NULL
to	NULL
that	NULL
found	NULL
with	NULL
9-cRA	NULL
but	NULL
the	NULL
inhibitory	NULL
threshold	NULL
was	NULL
found	NULL
to	NULL
be	NULL
5	NULL
um	NULL
,	NULL
that	NULL
is	NULL
to	NULL
say	NULL
500	NULL
fold	NULL
higher	NULL
than	NULL
the	NULL
threshold	NULL
for	NULL
9-cRA	NULL
antiproliferative	NULL
effect	NULL
.	NULL

9-cRA	NULL
at	NULL
1	NULL
nM	NULL
to	NULL
25	NULL
uM	NULL
neither	NULL
reduced	NULL
mesangial	NULL
cell	NULL
viability	NULL
as	NULL
judged	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
nor	NULL
induced	NULL
any	NULL
100	NULL
4	NULL
weet	NULL
é	NULL
deere	NULL
&	NULL
MTT	NULL
Reduction	NULL
(	NULL
%	NULL
Control	NULL
)	NULL
on	NULL
[	NULL
-	NULL
]	NULL
0	NULL
g-cRA	NULL
9	NULL
10°	NULL
10°	NULL
107	NULL
20	NULL
%	NULL
FCS	NULL
10°	NULL
M	NULL
Figure	NULL
1	NULL
Inhibition	NULL
by	NULL
9-cRA	NULL
of	NULL
FCS-stimulated	NULL
mesangial	NULL
cell	NULL
proliferation	NULL
(	NULL
measured	NULL
as	NULL
MTT	NULL
reduction	NULL
)	NULL
.	NULL

Quiescent	NULL
mesangial	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
9-cRA	NULL
.	NULL

FCS	NULL
(	NULL
20	NULL
%	NULL
)	NULL
or	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
medium	NULL
(	NULL
to	NULL
obtain	NULL
the	NULL
basal	NULL
values	NULL
of	NULL
every	NULL
experimental	NULL
condition	NULL
)	NULL
was	NULL
then	NULL
added	NULL
and	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h.	NULL
Cell	NULL
proliferation	NULL
was	NULL
quantified	NULL
by	NULL
measuring	NULL
the	NULL
ability	NULL
of	NULL
monolayers	NULL
to	NULL
reduce	NULL
exogenous	NULL
MTT	NULL
to	NULL
formazan	NULL
after	NULL
6	NULL
h	NULL
incubation	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
)	NULL
.	NULL

In	NULL
control	NULL
cells	NULL
,	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
absorbances	NULL
corresponding	NULL
to	NULL
20	NULL
%	NULL
FCS-stimulated	NULL
cells	NULL
versus	NULL
0.5	NULL
%	NULL
FCS-quiescent	NULL
cells	NULL
was	NULL
considered	NULL
as	NULL
100	NULL
%	NULL
.	NULL

In	NULL
9-cRA	NULL
treated	NULL
cells	NULL
,	NULL
the	NULL
difference	NULL
between	NULL
absorbances	NULL
found	NULL
in	NULL
20	NULL
%	NULL
FCS-stimulated	NULL
cells	NULL
versus	NULL
0.5	NULL
%	NULL
FCS	NULL
cells	NULL
was	NULL
obtained	NULL
and	NULL
then	NULL
results	NULL
were	NULL
expressed	NULL
as	NULL
per	NULL
cent	NULL
of	NULL
change	NULL
with	NULL
respect	NULL
the	NULL
100	NULL
%	NULL
established	NULL
for	NULL
control	NULL
cells	NULL
There	NULL
were	NULL
no	NULL
statistically	NULL
significant	NULL
differences	NULL
between	NULL
the	NULL
absorbances	NULL
found	NULL
in	NULL
0.5	NULL
%	NULL
FCS	NULL
cells	NULL
in	NULL
the	NULL
various	NULL
experimental	NULL
conditions	NULL
tested	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean+s.d	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
in	NULL
quadruplicate	NULL
.	NULL

ANOVA	NULL
,	NULL
***P	NULL
vs	NULL
0.	NULL
apoptosis	NULL
in	NULL
the	NULL
range	NULL
within	NULL
the	NULL
range	NULL
of	NULL
concentrations	NULL
tested	NULL
for	NULL
the	NULL
proliferation	NULL
studies	NULL
(	NULL
results	NULL
are	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
high	NULL
concentrations	NULL
of	NULL
retinoids	NULL
on	NULL
the	NULL
morphology	NULL
and	NULL
viability	NULL
of	NULL
mesangial	NULL
cells	NULL
We	NULL
first	NULL
performed	NULL
microscopic	NULL
examination	NULL
of	NULL
whether	NULL
occurrence	NULL
of	NULL
apoptosis	NULL
after	NULL
treatment	NULL
with	NULL
retinoids	NULL
occurred	NULL
in	NULL
CHMC	NULL
or	NULL
not	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
definitive	NULL
molecular	NULL
markers	NULL
,	NULL
morphologic	NULL
examination	NULL
is	NULL
the	NULL
only	NULL
way	NULL
to	NULL
be	NULL
sure	NULL
that	NULL
cells	NULL
are	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
McGahon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Before	NULL
treatment	NULL
,	NULL
the	NULL
mesangial	NULL
cells	NULL
grew	NULL
in	NULL
monolayers	NULL
until	NULL
confluence	NULL
was	NULL
reached	NULL
.	NULL

After	NULL
exposure	NULL
to	NULL
25	NULL
uM	NULL
tRA	NULL
or	NULL
50	NULL
um	NULL
9-cRA	NULL
for	NULL
24	NULL
to	NULL
72	NULL
h	NULL
,	NULL
however	NULL
,	NULL
significant	NULL
numbers	NULL
of	NULL
cells	NULL
showed	NULL
the	NULL
typical	NULL
morphology	NULL
of	NULL
apoptosis	NULL
including	NULL
pycnotic	NULL
nuclei	NULL
,	NULL
marked	NULL
chromatin	NULL
condensation	NULL
,	NULL
nuclear	NULL
fragmentation	NULL
into	NULL
spherical	NULL
structures	NULL
,	NULL
and	NULL
apoptotic	NULL
bodies	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
left	NULL
side	NULL
,	NULL
upper	NULL
panels	NULL
)	NULL
.	NULL

Such	NULL
cells	NULL
also	NULL
exhibited	NULL
condensed	NULL
chromatin	NULL
acridine	NULL
orange	NULL
dye	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
control	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
left	NULL
side	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

We	NULL
also	NULL
assessed	NULL
retinoid-induced	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
mesangial	NULL
cells	NULL
by	NULL
TUNEL	NULL
determination	NULL
of	NULL
DNA	NULL
fragmentation	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
TUNEL-positive	NULL
cells	NULL
-	NULL
this	NULL
indicating	NULL
the	NULL
occurrence	NULL
of	NULL
DNA	NULL
fragmentation	NULL
-	NULL
was	NULL
significantly	NULL
increased	NULL
by	NULL
incubation	NULL
of	NULL
cells	NULL
for	NULL
24	NULL
to	NULL
72	NULL
h	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
um	NULL
9-cRA	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
FCS	NULL
.	NULL

Again	NULL
50	NULL
uM	NULL
9-cRA	NULL
produced	NULL
similar	NULL
effects	NULL
than	NULL
25	NULL
uM	NULL
tRA	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Few	NULL
positive	NULL
cells	NULL
were	NULL
observed	NULL
when	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
this	NULL
was	NULL
a	NULL
consistent	NULL
background	NULL
level	NULL
of	NULL
apoptosis	NULL
.	NULL

Given	NULL
that	NULL
tRA	NULL
was	NULL
a	NULL
stronger	NULL
apoptosis	NULL
inductor	NULL
than	NULL
9-cRA	NULL
,	NULL
most	NULL
of	NULL
the	NULL
remaining	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
tRA	NULL
.	NULL

To	NULL
quantify	NULL
the	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
1677	NULL
effect	NULL
of	NULL
tRA	NULL
on	NULL
mesangial	NULL
cell	NULL
death	NULL
,	NULL
we	NULL
incubated	NULL
cells	NULL
for	NULL
various	NULL
intervals	NULL
of	NULL
time	NULL
with	NULL
25	NULL
uM	NULL
tRA	NULL
and	NULL
then	NULL
measured	NULL
both	NULL
total	NULL
cell	NULL
count	NULL
and	NULL
cell	NULL
viability	NULL
:	NULL
the	NULL
incubation	NULL
of	NULL
mesangial	NULL
cells	NULL
with	NULL
tRA	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
viable	NULL
cells	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
right	NULL
side	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
profile	NULL
of	NULL
catalase	NULL
activity	NULL
and	NULL
reduced	NULL
glutathione	NULL
content	NULL
during	NULL
tRA-induced	NULL
apoptosis	NULL
We	NULL
have	NULL
previously	NULL
found	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
that	NULL
non-apoptotic	NULL
concentrations	NULL
of	NULL
tRA	NULL
stimulate	NULL
catalase	NULL
activity	NULL
and	NULL
increase	NULL
reduced	NULL
glutathione	NULL
content	NULL
in	NULL
a	NULL
concentration-dependent	NULL
,	NULL
time-dependent	NULL
manner	NULL
.	NULL

Here	NULL
we	NULL
found	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
that	NULL
when	NULL
tRA	NULL
is	NULL
added	NULL
at	NULL
doses	NULL
high	NULL
enough	NULL
to	NULL
induce	NULL
apoptosis	NULL
,	NULL
there	NULL
is	NULL
also	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
antioxidant	NULL
defences	NULL
coinciding	NULL
with	NULL
the	NULL
development	NULL
of	NULL
the	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

We	NULL
then	NULL
studied	NULL
whether	NULL
there	NULL
was	NULL
a	NULL
cause-effect	NULL
relationship	NULL
by	NULL
exploring	NULL
two	NULL
opposite	NULL
possibilities	NULL
:	NULL
first	NULL
,	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
antioxidant	NULL
defences	NULL
is	NULL
a	NULL
defensive	NULL
cellular	NULL
response	NULL
to	NULL
oxidative	NULL
stress	NULL
,	NULL
which	NULL
is	NULL
relevant	NULL
since	NULL
oxygen	NULL
free	NULL
radicals	NULL
are	NULL
involved	NULL
in	NULL
several	NULL
models	NULL
of	NULL
apoptosis	NULL
(	NULL
Buttke	NULL
&	NULL
Sandstrom	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

However	NULL
,	NULL
preincubation	NULL
with	NULL
the	NULL
antioxidant	NULL
dl-x-tocopherol	NULL
,	NULL
or	NULL
with	NULL
catalase	NULL
,	NULL
which	NULL
specifically	NULL
detoxifies	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
or	NULL
with	NULL
with	NULL
the	NULL
cell-permeable	NULL
O	NULL
;	NULL
,	NULL
~	NULL
scavenger	NULL
tiron	NULL
(	NULL
Hein	NULL
,	NULL
1998	NULL
)	NULL
,	NULL
did	NULL
not	NULL
inhibit	NULL
tRA-induced	NULL
CHMC	NULL
apoptotic	NULL
death	NULL
.	NULL

Secondly	NULL
we	NULL
studied	NULL
the	NULL
possibility	NULL
that	NULL
catalase	NULL
and/or	NULL
GSH	NULL
were	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
apoptotic	NULL
signalling	NULL
.	NULL

Again	NULL
,	NULL
tRA-triggered	NULL
apoptosis	NULL
was	NULL
not	NULL
inhibited	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
by	NULL
amino-triazol	NULL
,	NULL
an	NULL
irreversible	NULL
inhibitor	NULL
of	NULL
catalase	NULL
activity	NULL
(	NULL
Aebi	NULL
,	NULL
1983	NULL
)	NULL
,	NULL
or	NULL
by	NULL
L-buthionine-	NULL
(	NULL
S-R	NULL
)	NULL
-sulphoximine	NULL
(	NULL
BSO	NULL
)	NULL
,	NULL
an	NULL
irreversible	NULL
inhibitor	NULL
of	NULL
y-glutamylcysteine	NULL
synthetase	NULL
,	NULL
the	NULL
rate-limiting	NULL
step	NULL
of	NULL
glutathione	NULL
synthesis	NULL
(	NULL
Griffith	NULL
,	NULL
1982	NULL
)	NULL
.	NULL

Prevention	NULL
of	NULL
H	NULL
;	NULL
0	NULL
-induced	NULL
cell	NULL
death	NULL
H	NULL
;	NULL
O	NULL
;	NULL
induces	NULL
concentration-dependent	NULL
damage	NULL
in	NULL
mesangial	NULL
cells	NULL
,	NULL
characterized	NULL
by	NULL
apoptosis	NULL
followed	NULL
by	NULL
secondary	NULL
necrosis	NULL
with	NULL
plasma	NULL
membrane	NULL
damage	NULL
resulting	NULL
in	NULL
loss	NULL
of	NULL
cytosolic	NULL
LDH	NULL
(	NULL
Moreno	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

H	NULL
,	NULL
O	NULL
;	NULL
-induced	NULL
LDH	NULL
release	NULL
is	NULL
clearly	NULL
abolished	NULL
by	NULL
tRA	NULL
,	NULL
within	NULL
a	NULL
narrow	NULL
concentration	NULL
range	NULL
:	NULL
10	NULL
uM	NULL
tRA	NULL
has	NULL
the	NULL
maximal	NULL
protective	NULL
action	NULL
against	NULL
H	NULL
;	NULL
O	NULL
;	NULL
and	NULL
1	NULL
uM	NULL
tRA	NULL
has	NULL
no	NULL
effect	NULL
at	NULL
all	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

Figure	NULL
3A	NULL
shows	NULL
the	NULL
results	NULL
obtained	NULL
when	NULL
using	NULL
retinoids	NULL
at	NULL
concentrations	NULL
high	NULL
enough	NULL
to	NULL
reach	NULL
maximal	NULL
prevention	NULL
against	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

It	NULL
is	NULL
clear	NULL
that	NULL
maximal	NULL
prevention	NULL
with	NULL
9-cRA	NULL
requires	NULL
a	NULL
1000	NULL
fold	NULL
lower	NULL
concentration	NULL
than	NULL
that	NULL
required	NULL
with	NULL
tRA	NULL
.	NULL

Since	NULL
H	NULL
;	NULL
O	NULL
»	NULL
-induced	NULL
cell	NULL
death	NULL
is	NULL
apoptotic	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19992	NULL
)	NULL
,	NULL
we	NULL
also	NULL
confirmed	NULL
by	NULL
morphological	NULL
examination	NULL
with	NULL
acridine	NULL
orange-ethidium	NULL
bromide	NULL
staining	NULL
that	NULL
apoptosis	NULL
was	NULL
suppressed	NULL
by	NULL
pretreatment	NULL
with	NULL
retinoids	NULL
(	NULL
results	NULL
are	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Table	NULL
1	NULL
Drugs	NULL
tested	NULL
for	NULL
inhibition	NULL
of	NULL
tRA-induced	NULL
apoptosis	NULL
Additional	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
assess	NULL
if	NULL
this	NULL
protective	NULL
effect	NULL
was	NULL
due	NULL
to	NULL
retinoid-induced	NULL
stimulation	NULL
of	NULL
antioxidant	NULL
defences	NULL
.	NULL

This	NULL
possibility	NULL
was	NULL
raised	NULL
from	NULL
previous	NULL
results	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
showing	NULL
that	NULL
catalase	NULL
activity	NULL
and	NULL
GSH	NULL
content	NULL
are	NULL
increased	NULL
by	NULL
2.5	NULL
fold	NULL
in	NULL
tRA-incubated	NULL
CHMC	NULL
.	NULL

We	NULL
studied	NULL
first	NULL
the	NULL
relative	NULL
potency	NULL
of	NULL
tRA	NULL
and	NULL
9-cRA	NULL
in	NULL
terms	NULL
of	NULL
maximal	NULL
stimulation	NULL
of	NULL
the	NULL
GSH	NULL
system	NULL
.	NULL

Time-course	NULL
experiments	NULL
have	NULL
previously	NULL
shown	NULL
(	NULL
Moreno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
that	NULL
a	NULL
48	NULL
h	NULL
incubation	NULL
with	NULL
10	NULL
uM	NULL
tRA	NULL
is	NULL
needed	NULL
to	NULL
reach	NULL
a	NULL
maximal	NULL
increase	NULL
in	NULL
the	NULL
intracellular	NULL
GSH	NULL
content	NULL
from	NULL
CHMC	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
here	NULL
the	NULL
relative	NULL
potency	NULL
of	NULL
the	NULL
two	NULL
retinoids	NULL
and	NULL
found	NULL
in	NULL
four	NULL
separate	NULL
experiments	NULL
in	NULL
triplicate	NULL
that	NULL
,	NULL
after	NULL
a	NULL
48	NULL
h	NULL
incubation	NULL
with	NULL
10	NULL
um	NULL
of	NULL
either	NULL
9-cRA	NULL
or	NULL
tRA	NULL
,	NULL
the	NULL
respective	NULL
intracellular	NULL
GSH	NULL
contents	NULL
(	NULL
nmol	NULL
mg~	NULL
'	NULL
protein	NULL
)	NULL
were	NULL
68	NULL
+5	NULL
and	NULL
53	NULL
+4	NULL
(	NULL
results	NULL
are	NULL
mean	NULL
Student	NULL
's	NULL
t-test	NULL
:	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
whereas	NULL
the	NULL
control	NULL
values	NULL
were	NULL
23	NULL
+3	NULL
:	NULL
that	NULL
is	NULL
to	NULL
say	NULL
,	NULL
9-cRA	NULL
was	NULL
a	NULL
stronger	NULL
inducer	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
GSH	NULL
than	NULL
tRA	NULL
.	NULL

However	NULL
,	NULL
stimulation	NULL
of	NULL
antioxidant	NULL
defences	NULL
by	NULL
retinoids	NULL
appears	NULL
not	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
preventive	NULL
effect	NULL
of	NULL
retinoids	NULL
against	NULL
H	NULL
;	NULL
O	NULL
;	NULL
since	NULL
preincubation	NULL
with	NULL
aminotriazole	NULL
(	NULL
an	NULL
irreversible	NULL
inhibitor	NULL
of	NULL
catalase	NULL
)	NULL
or	NULL
with	NULL
BSO	NULL
(	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
synthesis	NULL
of	NULL
glutathione	NULL
)	NULL
did	NULL
not	NULL
abolish	NULL
it	NULL
(	NULL
results	NULL
are	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
CHMC	NULL
incubated	NULL
with	NULL
these	NULL
retinoids	NULL
did	NULL
not	NULL
exhibit	NULL
a	NULL
higher	NULL
rate	NULL
of	NULL
catabolism	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
exogenously	NULL
added	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
The	NULL
co-culture	NULL
of	NULL
monocytes	NULL
with	NULL
the	NULL
FCS-stimulated	NULL
CHMC	NULL
resulted	NULL
in	NULL
time-dependent	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
the	NULL
underlying	NULL
mesangial	NULL
monolayer	NULL
.	NULL

Adhesion	NULL
was	NULL
substantially	NULL
inhibited	NULL
when	NULL
CHMC	NULL
were	NULL
pretreated	NULL
with	NULL
9-cRA	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
but	NULL
within	NULL
a	NULL
narrow	NULL
concentration	NULL
range	NULL
:	NULL
maximal	NULL
inhibition	NULL
was	NULL
found	NULL
at	NULL
1	NULL
uM	NULL
and	NULL
the	NULL
threshold	NULL
inhibition	NULL
appeared	NULL
at	NULL
10	NULL
nM	NULL
(	NULL
results	NULL
are	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
do	NULL
not	NULL
show	NULL
the	NULL
results	NULL
,	NULL
we	NULL
found	NULL
that	NULL
tRA	NULL
inhibited	NULL
adhesion	NULL
to	NULL
a	NULL
similar	NULL
extension	NULL
.	NULL

Changes	NULL
in	NULL
the	NULL
CHCM	NULL
expression	NULL
of	NULL
FN	NULL
,	NULL
OP	NULL
,	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
We	NULL
also	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
9-cRA	NULL
on	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
of	NULL
four	NULL
molecules	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
mesangial	NULL
cells	NULL
:	NULL
FN	NULL
,	NULL
OP	NULL
,	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
identical	NULL
experimental	NULL
conditions	NULL
to	NULL
those	NULL
used	NULL
in	NULL
the	NULL
study	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
,	NULL
excepting	NULL
that	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
instead	NULL
of	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

Results	NULL
obtained	NULL
may	NULL
be	NULL
classified	NULL
into	NULL
two	NULL
categories	NULL
:	NULL
those	NULL
related	NULL
to	NULL
molecules	NULL
secreted	NULL
by	NULL
CHMC	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
FN	NULL
and	NULL
OP	NULL
)	NULL
and	NULL
those	NULL
Drug	NULL
Action	NULL
Catalase	NULL
(	NULL
32,000	NULL
L	NULL
.	NULL

U	NULL
.	NULL
)	NULL

dl-z-tocopherol	NULL
(	NULL
50	NULL
um	NULL
)	NULL
Aminotriazole	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
H	NULL
,	NULL
O	NULL
;	NULL
detoxification	NULL
Antioxidant	NULL
Catalase	NULL
inhibitor	NULL
BSO	NULL
(	NULL
0.2	NULL
mm	NULL
)	NULL
y-Glutamylcysteine	NULL
synthetase	NULL
inhibitor	NULL
Tiron	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
Superoxide	NULL
anion	NULL
scavenger	NULL
Inhibits	NULL
tR	NULL
A-induced	NULL
Effect	NULL
on	NULL
CHMC	NULL
CHMC	NULL
apoptosis	NULL
-	NULL
no	NULL
-	NULL
no	NULL
Inhibits	NULL
tRA-induced	NULL
increase	NULL
no	NULL
in	NULL
catalase	NULL
activity*	NULL
Inhibits	NULL
tRA-induced	NULL
increase	NULL
no	NULL
in	NULL
cellular	NULL
GSH	NULL
content**	NULL
-	NULL
no	NULL
*Catalase	NULL
activity	NULL
(	NULL
mK	NULL
mg~	NULL
'	NULL
protein	NULL
)	NULL
in	NULL
CHMC	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
25	NULL
um	NULL
tRA	NULL
was	NULL
104.8+13.1	NULL
vs	NULL
1.3+1.1	NULL
when	NULL
cells	NULL
were	NULL
previously	NULL
treated	NULL
with	NULL
aminotriazole	NULL
for	NULL
1	NULL
h.	NULL
**Intracellular	NULL
GSH	NULL
content	NULL
(	NULL
nmol	NULL
mg~	NULL
'	NULL
protein	NULL
)	NULL
in	NULL
CHMC	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
25	NULL
um	NULL
tRA	NULL
was	NULL
58.3+6.9	NULL
vs	NULL
8.8	NULL
+2.2	NULL
when	NULL
cells	NULL
were	NULL
previously	NULL
treated	NULL
with	NULL
BSO	NULL
for	NULL
1	NULL
h.	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
1678	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
A	NULL
)	NULL
CONTROL	NULL
tRA	NULL
(	NULL
25	NULL
pM	NULL
)	NULL
.	NULL

.	NULL

®	NULL
#	NULL
i	NULL
&	NULL
ugh	NULL
*	NULL
a	NULL
100	NULL
+	NULL
,	NULL
``	NULL
k	NULL
£	NULL
#	NULL
.	NULL

al	NULL
¥	NULL
V	NULL
&	NULL
L	NULL
2	NULL
so	NULL
>	NULL
s	NULL
O	NULL
0	NULL
Cree	NULL
+	NULL
)	NULL
controu	NULL
9-cRA	NULL
(	NULL
50	NULL
pM	NULL
)	NULL
@	NULL
c	NULL
)	NULL
300	NULL
jou	NULL
200	NULL
100	NULL
%	NULL
Change	NULL
vs	NULL
Control	NULL
0	NULL
tRA	NULL
(	NULL
25	NULL
uM	NULL
)	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Catalase	NULL
GSH	NULL
Figure	NULL
2	NULL
Retinoid-induced	NULL
apoptosis	NULL
in	NULL
CHMC	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
high	NULL
concentrations	NULL
of	NULL
tRA	NULL
on	NULL
the	NULL
morphology	NULL
and	NULL
viability	NULL
of	NULL
CHMC	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
shows	NULL
light	NULL
microphotographs	NULL
(	NULL
upper	NULL
panels	NULL
)	NULL
where	NULL
apoptotic	NULL
mesangial	NULL
cells	NULL
exhibits	NULL
nuclear	NULL
fragmentation	NULL
into	NULL
spherical	NULL
structures	NULL
and	NULL
condensed	NULL
cytoplasm	NULL
,	NULL
but	NULL
they	NULL
are	NULL
still	NULL
surrounded	NULL
by	NULL
a	NULL
cell	NULL
membrane	NULL
,	NULL
and	NULL
fluorescent	NULL
microphotographs	NULL
(	NULL
lower	NULL
panels	NULL
)	NULL
where	NULL
several	NULL
nuclei	NULL
with	NULL
condensed	NULL
chromatin	NULL
are	NULL
observed	NULL
.	NULL

The	NULL
right	NULL
panel	NULL
shows	NULL
the	NULL
decrease	NULL
in	NULL
viable	NULL
cells	NULL
(	NULL
as	NULL
assessed	NULL
by	NULL
direct	NULL
count	NULL
under	NULL
light	NULL
microscopy	NULL
of	NULL
cells	NULL
excluding	NULL
trypan	NULL
blue	NULL
dye	NULL
)	NULL
after	NULL
24	NULL
h	NULL
incubation	NULL
with	NULL
25	NULL
um	NULL
tRA	NULL
(	NULL
Student	NULL
's	NULL
:	NULL
-test	NULL
***P	NULL
<	NULL
0.001	NULL
vs	NULL
control	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
9-cRA	NULL
on	NULL
DNA	NULL
fragmentation	NULL
in	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells	NULL
Cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
control	NULL
conditions	NULL
or	NULL
with	NULL
50	NULL
um	NULL
9-cRA	NULL
.	NULL

Then	NULL
TUNEL	NULL
staining	NULL
was	NULL
performed	NULL
using	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
,	NULL
an	NULL
enzyme	NULL
which	NULL
catalyzes	NULL
incorporation	NULL
of	NULL
fluorescein-dUTP	NULL
at	NULL
sites	NULL
of	NULL
DNA	NULL
breaks	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
amplified	NULL
by	NULL
alkaline	NULL
phosphatase	NULL
enzyme	NULL
.	NULL

Apoptotic	NULL
cells	NULL
appear	NULL
as	NULL
red	NULL
nuclei	NULL
whereas	NULL
non-apoptotic	NULL
cells	NULL
were	NULL
non-stained	NULL
.	NULL

Micrographs	NULL
correspond	NULL
to	NULL
control	NULL
cells	NULL
(	NULL
left	NULL
)	NULL
or	NULL
to	NULL
9-cRA	NULL
incubated	NULL
cells	NULL
(	NULL
right	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effect	NULL
25	NULL
uM	NULL
tRA	NULL
on	NULL
the	NULL
catalase	NULL
activity	NULL
and	NULL
reduced	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
content	NULL
in	NULL
CHMC	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
control	NULL
conditions	NULL
or	NULL
with	NULL
25	NULL
um	NULL
tRA	NULL
.	NULL

Then	NULL
catalase	NULL
activity	NULL
and	NULL
GSH	NULL
content	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

(	NULL
Student	NULL
's	NULL
t-test	NULL
***p	NULL
<	NULL
0.001	NULL
vs	NULL
control	NULL
)	NULL
.	NULL

involving	NULL
cell	NULL
adhesion	NULL
molecules	NULL
present	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
mesangial	NULL
cells	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
)	NULL
.	NULL

9-cRA	NULL
inhibited	NULL
OP	NULL
and	NULL
FN	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
(	NULL
Figures	NULL
5	NULL
and	NULL
6	NULL
)	NULL
in	NULL
FCS-stimulated	NULL
mesangial	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
9-cRA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
nor	NULL
on	NULL
the	NULL
ICAM-l	NULL
protein	NULL
expression	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
9-cRA	NULL
stimulated	NULL
VCAM-1	NULL
mRNA	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
this	NULL
effect	NULL
did	NULL
not	NULL
result	NULL
in	NULL
increased	NULL
VCAM-1	NULL
protein	NULL
expression	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
,	NULL
this	NULL
being	NULL
probably	NULL
due	NULL
to	NULL
A	NULL
)	NULL
_	NULL
100	NULL
_L	NULL
,	NULL
C	NULL
1	NULL
0	NULL
0	NULL
290	NULL
weg	NULL
C23	NULL
0	NULL
&	NULL
~	NULL
50	NULL
E	NULL
Seik	NULL
&	NULL
I	NULL
.	NULL

”	NULL
delet	NULL
u	NULL
wt	NULL
o	NULL
_I	NULL
0	NULL
9-cRA	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
-	NULL
-	NULL
+	NULL
og	NULL
-L	NULL
tRA	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
-	NULL
+-	NULL
Lon	NULL
+	NULL
H0	NULL
;	NULL
(	NULL
uM	NULL
)	NULL
25	NULL
100	NULL
B	NULL
)	NULL
100	NULL
{	NULL
250K	NULL
--	NULL
XK-X	NULL
--	NULL
--	NULL
-X	NULL
--	NULL
--	NULL
X	NULL
-O-	NULL
tRA	NULL
10pM	NULL
-_-	NULL
IcRA	NULL
10	NULL
nM	NULL
-A-	NULL
control	NULL
-X-	NULL
no	NULL
cells	NULL
Hydrogen	NULL
peroxide	NULL
(	NULL
uM	NULL
)	NULL
10	NULL
20	NULL
Time	NULL
(	NULL
minutes	NULL
)	NULL
Figure	NULL
3	NULL
(	NULL
A	NULL
)	NULL
Prevention	NULL
by	NULL
retinoids	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-induced	NULL
cytotoxicity	NULL
.	NULL

Confluent	NULL
,	NULL
quiescent	NULL
CHMC	NULL
cultured	NULL
in	NULL
96-well	NULL
microtiter	NULL
plates	NULL
,	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
either	NULL
10	NULL
nm	NULL
9-cRA	NULL
or	NULL
10	NULL
um	NULL
tRA	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
either	NULL
25	NULL
or	NULL
100	NULL
um	NULL
H	NULL
,	NULL
O	NULL
;	NULL
Control	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
parallel	NULL
but	NULL
without	NULL
adding	NULL
retinoids	NULL
and	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

Cytotoxicity	NULL
was	NULL
quantified	NULL
by	NULL
measuring	NULL
LDH	NULL
efflux	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
the	NULL
damaged	NULL
cells	NULL
to	NULL
the	NULL
supernatant	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
per	NULL
cent	NULL
of	NULL
the	NULL
control	NULL
value	NULL
(	NULL
LDH	NULL
released	NULL
by	NULL
control	NULL
cells	NULL
incubated	NULL
with	NULL
2	NULL
%	NULL
Triton-X-100	NULL
was	NULL
considered	NULL
as	NULL
100	NULL
%	NULL
LDH	NULL
efflux	NULL
)	NULL
and	NULL
are	NULL
mean+s.d	NULL
.	NULL

of	NULL
three	NULL
separate	NULL
experiments	NULL
in	NULL
quadruplicate	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
10	NULL
nm	NULL
9-cRA	NULL
and	NULL
10	NULL
um	NULL
tRA	NULL
prevented	NULL
in	NULL
a	NULL
similar	NULL
extension	NULL
the	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-induced	NULL
loss	NULL
of	NULL
cell	NULL
viability	NULL
(	NULL
***P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

No	NULL
differences	NULL
in	NULL
LDH	NULL
release	NULL
were	NULL
found	NULL
beween	NULL
control	NULL
cells	NULL
and	NULL
cells	NULL
incubated	NULL
with	NULL
9-cRA	NULL
or	NULL
tRA	NULL
(	NULL
results	NULL
are	NULL
not	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Consumption	NULL
of	NULL
H	NULL
;	NULL
O	NULL
by	NULL
cells	NULL
incubated	NULL
with	NULL
retinoids	NULL
.	NULL

Confluent	NULL
,	NULL
quiescent	NULL
CHMC	NULL
cultured	NULL
in	NULL
35	NULL
mm	NULL
Petri	NULL
dishes	NULL
,	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
with	NULL
either	NULL
10	NULL
nm	NULL
9-cRA	NULL
or	NULL
10	NULL
um	NULL
tRA	NULL
in	NULL
order	NULL
to	NULL
stimulate	NULL
maximally	NULL
antioxidant	NULL
defences	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
100	NULL
um	NULL
H	NULL
,	NULL
O	NULL
;	NULL
from	NULL
0	NULL
to	NULL
22	NULL
min	NULL
.	NULL

Control	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
parallel	NULL
but	NULL
without	NULL
adding	NULL
retinoids	NULL
.	NULL

At	NULL
the	NULL
times	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
was	NULL
measured	NULL
in	NULL
an	NULL
aliquot	NULL
of	NULL
medium	NULL
by	NULL
the	NULL
horseradish	NULL
peroxidase-mediated	NULL
oxidation	NULL
of	NULL
phenol	NULL
red	NULL
method	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+s.d	NULL
.	NULL

of	NULL
three	NULL
separate	NULL
experiments	NULL
in	NULL
triplicate	NULL
.	NULL

No	NULL
statistically	NULL
significant	NULL
differences	NULL
were	NULL
found	NULL
in	NULL
the	NULL
consumption	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
between	NULL
the	NULL
three	NULL
experimental	NULL
groups	NULL
(	NULL
ANOVA	NULL
P	NULL
>	NULL
0.05	NULL
)	NULL
.	NULL

British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
1679	NULL
*	NULL
9-cRA	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
0	NULL
2	NULL
4	NULL
8	NULL
24	NULL
-	NULL
(	NULL
h	NULL
)	NULL
150	NULL
<	NULL
A	NULL
vehicle	NULL
45	NULL
KDa	NULL
-	NULL
WWW	NULL
|	NULL
cmm	NULL
.	NULL

s	NULL
e	NULL
£	NULL
OP	NULL
9-cRA	NULL
wa	NULL
o	NULL
&	NULL
M	NULL
Monocyte	NULL
Adhesion	NULL
(	NULL
%	NULL
Control	NULL
)	NULL
S	NULL
0	NULL
FCS	NULL
0.5	NULL
%	NULL
20	NULL
%	NULL
Figure	NULL
4	NULL
Inhibition	NULL
by	NULL
retinoids	NULL
of	NULL
the	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells	NULL
.	NULL

Confluent	NULL
CHMC	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
20	NULL
%	NULL
FCS	NULL
containing	NULL
1	NULL
um	NULL
9-cRA	NULL
or	NULL
vehicle	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
human	NULL
monocytes	NULL
,	NULL
isolated	NULL
from	NULL
blood	NULL
from	NULL
healthy	NULL
donors	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
,	NULL
were	NULL
added	NULL
to	NULL
CHMC	NULL
.	NULL

After	NULL
coincubation	NULL
for	NULL
2	NULL
h	NULL
,	NULL
the	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
CHMC	NULL
was	NULL
quantified	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
mean+s.d	NULL
.	NULL

of	NULL
three	NULL
different	NULL
experiments	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
actual	NULL
value	NULL
for	NULL
100	NULL
%	NULL
adhesion	NULL
was	NULL
71+8	NULL
monocytes	NULL
per	NULL
well	NULL
*P	NULL
<	NULL
0.05	NULL
vs	NULL
vehicle	NULL
.	NULL

A	NULL
)	NULL
0	NULL
2	NULL
4	NULL
8	NULL
12	NULL
24	NULL
hours	NULL
1.7	NULL
Kbp	NULL
“	NULL
h	NULL
«	NULL
oP	NULL
15	NULL
an	NULL
AD	NULL
WD	NULL
caron	NULL
B	NULL
)	NULL
0	NULL
2	NULL
4	NULL
8	NULL
24	NULL
-	NULL
hours	NULL
$	NULL
Kp	NULL
CB	NULL
.	NULL

+	NULL
FN	NULL
Figure	NULL
5	NULL
Effect	NULL
of	NULL
9-cRA	NULL
on	NULL
osteopontin	NULL
and	NULL
fibronectin	NULL
mRNA	NULL
expression	NULL
in	NULL
human	NULL
mesangial	NULL
cells	NULL
.	NULL

Confluent	NULL
human	NULL
mesangial	NULL
cells	NULL
were	NULL
incubated	NULL
up	NULL
to	NULL
24	NULL
h	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
with	NULL
1	NULL
um	NULL
9-cRA	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
.	NULL

Northern	NULL
blotting	NULL
for	NULL
OP	NULL
(	NULL
A	NULL
)	NULL
and	NULL
FN	NULL
(	NULL
B	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
for	NULL
the	NULL
housekeeping	NULL
gene	NULL
GAPDH	NULL
to	NULL
adjust	NULL
for	NULL
small	NULL
variations	NULL
in	NULL
RNA	NULL
loading	NULL
and	NULL
transfer	NULL
to	NULL
the	NULL
filter	NULL
.	NULL

The	NULL
autoradiograms	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

the	NULL
fact	NULL
that	NULL
post-transcriptional	NULL
mechanisms	NULL
may	NULL
be	NULL
relevant	NULL
determinants	NULL
of	NULL
VCAM-1	NULL
protein	NULL
expression	NULL
(	NULL
Lademarco	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Pietersma	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
do	NULL
not	NULL
show	NULL
the	NULL
results	NULL
,	NULL
tRA	NULL
had	NULL
similar	NULL
effects	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
four	NULL
adhesion	NULL
molecules	NULL
.	NULL

270	NULL
KDa	NULL
F	NULL
F-	NULL
bm	NULL
&	NULL
~	NULL
FN	NULL
i	NULL
VCAM-1	NULL
110	NULL
KDa	NULL
=	NULL
95	NULL
KDa	NULL
L	NULL
LL-	NULL
tthe	NULL
th	NULL
-	NULL
ICAM-1	NULL
Figure	NULL
6	NULL
Effect	NULL
of	NULL
9-cRA	NULL
on	NULL
the	NULL
protein	NULL
expression	NULL
of	NULL
osteopontin	NULL
,	NULL
fibronectin	NULL
,	NULL
VCAM-1	NULL
and	NULL
ICAM-1	NULL
in	NULL
human	NULL
mesangial	NULL
cells	NULL
.	NULL

Confluent	NULL
human	NULL
mesangial	NULL
cells	NULL
were	NULL
incubated	NULL
up	NULL
to	NULL
24	NULL
h	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
with	NULL
1	NULL
um	NULL
9-cRA	NULL
and	NULL
total	NULL
protein	NULL
was	NULL
extracted	NULL
.	NULL

Twenty	NULL
ug	NULL
of	NULL
every	NULL
protein	NULL
extract	NULL
was	NULL
electrophoresed	NULL
and	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
.	NULL

Membranes	NULL
were	NULL
probed	NULL
with	NULL
primary	NULL
antibodies	NULL
against	NULL
OP	NULL
,	NULL
FN	NULL
,	NULL
VCAM	NULL
and	NULL
ICAM-1	NULL
and	NULL
blots	NULL
were	NULL
developed	NULL
using	NULL
secondary	NULL
antibodies	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
for	NULL
viewing	NULL
enhanced	NULL
chemiluminescence	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Expression	NULL
of	NULL
mRNA	NULL
for	NULL
RARs	NULL
and	NULL
RXRs	NULL
in	NULL
mesangial	NULL
cells	NULL
and	NULL
its	NULL
modulation	NULL
by	NULL
9-cRA	NULL
We	NULL
characterized	NULL
the	NULL
steady	NULL
state	NULL
mRNA	NULL
levels	NULL
of	NULL
all	NULL
six	NULL
retinoid	NULL
receptors	NULL
as	NULL
well	NULL
as	NULL
their	NULL
regulation	NULL
by	NULL
9-cRA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
all	NULL
major	NULL
RARs	NULL
isotypes	NULL
were	NULL
expressed	NULL
in	NULL
CHMC	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
9-cRA	NULL
.	NULL

Transcripts	NULL
to	NULL
RAR-	NULL
«	NULL
have	NULL
been	NULL
previously	NULL
found	NULL
both	NULL
in	NULL
normal	NULL
human	NULL
renal	NULL
tissue	NULL
(	NULL
De	NULL
Thé	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
in	NULL
12	NULL
human	NULL
renal	NULL
cell	NULL
carcinoma	NULL
lines	NULL
(	NULL
Hoffman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
these	NULL
lines	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
failed	NULL
to	NULL
increase	NULL
RAR-	NULL
«	NULL
expression	NULL
(	NULL
Hoffman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
this	NULL
result	NULL
being	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
9-cRA-triggered	NULL
induction	NULL
of	NULL
this	NULL
receptor	NULL
in	NULL
CHMC	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

RAR-y	NULL
mRNA	NULL
expression	NULL
was	NULL
also	NULL
present	NULL
in	NULL
CHMC	NULL
and	NULL
it	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
9-cRA	NULL
.	NULL

Although	NULL
previous	NULL
studies	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
renal	NULL
expression	NULL
of	NULL
this	NULL
receptor	NULL
may	NULL
be	NULL
modulated	NULL
by	NULL
nuclear	NULL
hormones	NULL
such	NULL
as	NULL
androgens	NULL
(	NULL
Huang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
the	NULL
retinoid	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
RAR-y	NULL
expression	NULL
in	NULL
renal	NULL
cell	NULL
carcinoma	NULL
lines	NULL
(	NULL
Hoffman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Low	NULL
but	NULL
reproducibly	NULL
detectable	NULL
transcripts	NULL
to	NULL
RAR-8	NULL
were	NULL
also	NULL
present	NULL
in	NULL
CHMC	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
9-cRA	NULL
increased	NULL
their	NULL
levels	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
RAR-§	NULL
mRNA	NULL
has	NULL
also	NULL
been	NULL
documented	NULL
in	NULL
several	NULL
cell	NULL
lines	NULL
after	NULL
9-cRA	NULL
treatment	NULL
(	NULL
Lovat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Levin	NULL
&	NULL
Davis	NULL
,	NULL
1997	NULL
)	NULL
and	NULL
it	NULL
has	NULL
been	NULL
related	NULL
to	NULL
the	NULL
antiproliferative	NULL
effects	NULL
of	NULL
13-cis-retinoic	NULL
acid	NULL
in	NULL
human	NULL
renal	NULL
cell	NULL
carcinomas	NULL
(	NULL
Hoffman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
to	NULL
the	NULL
response	NULL
of	NULL
renal	NULL
cancer	NULL
patients	NULL
to	NULL
13-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
Berg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
a	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
located	NULL
on	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
RAR-	NULL
$	NULL
gene	NULL
suggests	NULL
that	NULL
the	NULL
gene	NULL
might	NULL
amplify	NULL
the	NULL
response	NULL
to	NULL
retinoids	NULL
in	NULL
target	NULL
tissues	NULL
by	NULL
raising	NULL
its	NULL
own	NULL
receptor	NULL
expression	NULL
level	NULL
(	NULL
Orfanos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
all	NULL
major	NULL
RXRs	NULL
isotypes	NULL
were	NULL
also	NULL
expressed	NULL
in	NULL
CHMC	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
9-cRA	NULL
.	NULL

Regarding	NULL
RXR-§	NULL
and	NULL
RXR-y	NULL
,	NULL
these	NULL
findings	NULL
are	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
showing	NULL
that	NULL
rat	NULL
glomeruli	NULL
express	NULL
RXR-§	NULL
transcripts	NULL
(	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
and	NULL
RXR-y	NULL
protein	NULL
(	NULL
Sugawara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
studies	NULL
failed	NULL
to	NULL
find	NULL
transcripts	NULL
to	NULL
RXR-	NULL
«	NULL
and	NULL
RXR-	NULL
«	NULL
protein	NULL
in	NULL
glomeruli	NULL
and	NULL
this	NULL
contrasts	NULL
with	NULL
our	NULL
results	NULL
since	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
1680	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
RARy	NULL
-	NULL
288	NULL
rRNA	NULL
v1	NULL
.	NULL

N	NULL
+	NULL
<	NULL
+	NULL
#	NULL
3	NULL
+	NULL
t*	NULL
#	NULL
#	NULL
.	NULL

-	NULL
rRNA	NULL
0	NULL
2	NULL
4	NULL
8	NULL
(	NULL
M	NULL
)	NULL
0	NULL
20	NULL
4	NULL
8	NULL
(	NULL
h	NULL
)	NULL
)	NULL
0	NULL
204	NULL
8	NULL
(	NULL
b	NULL
)	NULL
awn	NULL
wa	NULL
dh	NULL
%	NULL
cars	NULL
do	NULL
dp	NULL
@	NULL
RXR	NULL
a	NULL
RXR	NULL
B	NULL
RXR	NULL
y	NULL
L	NULL
<	NULL
+	NULL
*-	NULL
#	NULL
p	NULL
as	NULL
an	NULL
as	NULL
gas	NULL
on	NULL
r	NULL
Ta	NULL
R	NULL
H	NULL
<	NULL
-	NULL
@	NULL
w	NULL
I	NULL
»	NULL
w	NULL
©1893	NULL
rRNA	NULL
0	NULL
2	NULL
4	NULL
8	NULL
(	NULL
M-	NULL
0	NULL
20	NULL
4	NULL
8	NULL
(	NULL
M	NULL
)	NULL
)	NULL
0	NULL
20040	NULL
§	NULL
(	NULL
b	NULL
)	NULL
os	NULL
<	NULL
>	NULL
ap	NULL
@	NULL
@	NULL
®	NULL
®	NULL
-	NULL
a	NULL
ae	NULL
an	NULL
ae	NULL
=	NULL
Garo	NULL
:	NULL
Figure	NULL
7	NULL
Expression	NULL
of	NULL
mRNA	NULL
for	NULL
RARs	NULL
and	NULL
RXRs	NULL
and	NULL
its	NULL
modulation	NULL
by	NULL
9-cRA	NULL
.	NULL

Quiescent	NULL
,	NULL
confluent	NULL
human	NULL
mesangial	NULL
cells	NULL
were	NULL
incubated	NULL
up	NULL
to	NULL
8	NULL
h	NULL
with	NULL
1	NULL
um	NULL
9-cRA	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
.	NULL

Northern	NULL
blot	NULL
for	NULL
the	NULL
subtypes	NULL
«	NULL
,	NULL
#	NULL
and	NULL
y	NULL
of	NULL
either	NULL
RAR	NULL
or	NULL
RXR	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
for	NULL
the	NULL
housekeeping	NULL
gene	NULL
GAPDH	NULL
to	NULL
adjust	NULL
for	NULL
small	NULL
variations	NULL
in	NULL
RNA	NULL
loading	NULL
and	NULL
transfer	NULL
to	NULL
the	NULL
filter	NULL
.	NULL

The	NULL
autoradiograms	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

A	NULL
second	NULL
RXRy	NULL
autoradiogram	NULL
with	NULL
lower	NULL
exposition	NULL
is	NULL
also	NULL
shown	NULL
(	NULL
centre	NULL
right	NULL
)	NULL
in	NULL
order	NULL
to	NULL
improve	NULL
the	NULL
observation	NULL
of	NULL
the	NULL
two	NULL
bands	NULL
between	NULL
28S	NULL
and	NULL
188	NULL
rRNA	NULL
.	NULL

we	NULL
have	NULL
found	NULL
mRNA	NULL
for	NULL
RXR-	NULL
«	NULL
in	NULL
glomerular	NULL
CHMC	NULL
.	NULL

Interestingly	NULL
,	NULL
RXR-	NULL
«	NULL
transcripts	NULL
have	NULL
also	NULL
been	NULL
found	NULL
in	NULL
cultured	NULL
rat	NULL
mesangial	NULL
cells	NULL
(	NULL
Q.	NULL
Xu	NULL
&	NULL
M.	NULL
Kitamura	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

9-cRA	NULL
increased	NULL
the	NULL
expression	NULL
of	NULL
RXR-	NULL
«	NULL
and	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
RXR-y	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
RXRs	NULL
may	NULL
be	NULL
particularly	NULL
relevant	NULL
since	NULL
they	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
function	NULL
as	NULL
coregulators	NULL
that	NULL
enhance	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
(	NULL
including	NULL
RARs	NULL
,	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
,	NULL
vitamin	NULL
D	NULL
receptor	NULL
and	NULL
peroxi-some	NULL
proliferator-activated	NULL
receptors	NULL
)	NULL
to	NULL
their	NULL
cognate	NULL
response	NULL
elements	NULL
(	NULL
reviewed	NULL
by	NULL
Giguere	NULL
,	NULL
1999	NULL
)	NULL
.	NULL

Discussion	NULL
Glomerular	NULL
cells	NULL
and	NULL
especially	NULL
mesangial	NULL
cells	NULL
play	NULL
an	NULL
active	NULL
part	NULL
in	NULL
the	NULL
inflammatory	NULL
response	NULL
to	NULL
glomerular	NULL
injury	NULL
(	NULL
Pfeilschifter	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
work	NULL
is	NULL
mainly	NULL
a	NULL
prospective	NULL
study	NULL
on	NULL
the	NULL
possibility	NULL
that	NULL
9-cRA	NULL
may	NULL
act	NULL
as	NULL
an	NULL
anti-inflammatory	NULL
agent	NULL
at	NULL
the	NULL
mesangial	NULL
cell	NULL
level	NULL
.	NULL

The	NULL
approach	NULL
involved	NULL
the	NULL
study	NULL
of	NULL
three	NULL
relevant	NULL
effects	NULL
:	NULL
inhibition	NULL
of	NULL
CHMC	NULL
proliferation	NULL
,	NULL
prevention	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-induced	NULL
mesangial	NULL
cell	NULL
death	NULL
,	NULL
and	NULL
inhibition	NULL
by	NULL
retinoids	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
.	NULL

Glomerular	NULL
mesangial	NULL
cell	NULL
proliferation	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
many	NULL
types	NULL
of	NULL
progressive	NULL
glomerular	NULL
disease	NULL
(	NULL
Pfeilschifter	NULL
,	NULL
1994	NULL
)	NULL
and	NULL
its	NULL
inhibition	NULL
has	NULL
,	NULL
therefore	NULL
,	NULL
a	NULL
potential	NULL
therapeutic	NULL
interest	NULL
.	NULL

9-cRA	NULL
had	NULL
antiproliferative	NULL
action	NULL
on	NULL
CHMC	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
,	NULL
a	NULL
well	NULL
known	NULL
effect	NULL
of	NULL
retinoids	NULL
on	NULL
many	NULL
normal	NULL
and	NULL
transformed	NULL
cells	NULL
(	NULL
Giguere	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

tRA	NULL
also	NULL
inhibited	NULL
CHMC	NULL
proliferation-although	NULL
the	NULL
concentration	NULL
required	NULL
was	NULL
500	NULL
fold	NULL
higher-and	NULL
this	NULL
effect	NULL
has	NULL
been	NULL
attributted	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
activating	NULL
protein-1	NULL
activity	NULL
in	NULL
CHMC	NULL
(	NULL
Simonson	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Ligand-activated	NULL
RARs	NULL
,	NULL
which	NULL
are	NULL
able	NULL
to	NULL
inhibit	NULL
activating-protein-1	NULL
activity	NULL
(	NULL
Giguere	NULL
,	NULL
1994	NULL
)	NULL
,	NULL
have	NULL
been	NULL
traditionally	NULL
linked	NULL
to	NULL
the	NULL
antiproliferative	NULL
effect	NULL
of	NULL
retinoids	NULL
.	NULL

Therefore	NULL
this	NULL
could	NULL
be	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
through	NULL
which	NULL
9-cRA	NULL
,	NULL
an	NULL
RAR	NULL
ligand	NULL
(	NULL
Allenby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
exerts	NULL
its	NULL
antiproliferative	NULL
effect	NULL
on	NULL
CHMC	NULL
.	NULL

However	NULL
,	NULL
a	NULL
contribution	NULL
of	NULL
RXRs	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
:	NULL
recent	NULL
work	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
RXRs	NULL
by	NULL
selective	NULL
retinoids	NULL
can	NULL
also	NULL
mediate	NULL
growth	NULL
inhibitory	NULL
effects	NULL
(	NULL
Wan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
and	NULL
9-cRA	NULL
activates	NULL
both	NULL
RARs	NULL
and	NULL
RXRs	NULL
(	NULL
Heyman	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Levin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
potent	NULL
growth-inhibitory	NULL
properties	NULL
of	NULL
9-cRA	NULL
on	NULL
serum-stimulated	NULL
CHMC	NULL
are	NULL
not	NULL
associated	NULL
with	NULL
cytotoxicity	NULL
.	NULL

However	NULL
,	NULL
we	NULL
asked	NULL
if	NULL
higher	NULL
concentrations	NULL
are	NULL
toxic	NULL
for	NULL
CHMC	NULL
and	NULL
we	NULL
found	NULL
that	NULL
concentrations	NULL
of	NULL
9-cRA	NULL
higher	NULL
than	NULL
50	NULL
um	NULL
induced	NULL
apoptosis	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

This	NULL
concentration	NULL
is	NULL
much	NULL
greater	NULL
than	NULL
the	NULL
concentrations	NULL
required	NULL
for	NULL
the	NULL
effects	NULL
with	NULL
a	NULL
potential	NULL
anti-inflammatory	NULL
value	NULL
(	NULL
see	NULL
Results	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
apoptosis	NULL
in	NULL
CHMC	NULL
was	NULL
found	NULL
with	NULL
25	NULL
uM	NULL
tRA	NULL
(	NULL
that	NULL
is	NULL
to	NULL
say	NULL
,	NULL
a	NULL
concentration	NULL
slightly	NULL
higher	NULL
than	NULL
that	NULL
needed	NULL
to	NULL
obtain	NULL
anti-inflammatory	NULL
effects	NULL
)	NULL
,	NULL
although	NULL
the	NULL
onset	NULL
of	NULL
tRA-induced	NULL
apoptosis	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
strong	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
1681	NULL
increase	NULL
in	NULL
both	NULL
catalase	NULL
activity	NULL
and	NULL
GSH	NULL
.	NULL

Further	NULL
studies	NULL
using	NULL
several	NULL
modulators	NULL
(	NULL
see	NULL
the	NULL
Results	NULL
section	NULL
)	NULL
did	NULL
not	NULL
confirm	NULL
our	NULL
effect	NULL
suggesting	NULL
that	NULL
the	NULL
oxidation/antioxidation	NULL
balance	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
retinoid-induced	NULL
apoptosis	NULL
.	NULL

RARs	NULL
are	NULL
,	NULL
on	NULL
the	NULL
contrary	NULL
,	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
retinoid-induced	NULL
CHMC	NULL
apoptosis	NULL
since	NULL
TTNPB	NULL
,	NULL
another	NULL
RAR	NULL
pan-agonist	NULL
like	NULL
tRA	NULL
(	NULL
Orfanos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
induced	NULL
apoptosis	NULL
at	NULL
concentrations	NULL
as	NULL
low	NULL
as	NULL
10	NULL
uM	NULL
(	NULL
F.J.	NULL
Lucio	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
for	NULL
the	NULL
prevention	NULL
by	NULL
retinoids	NULL
of	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
-induced	NULL
mesangial	NULL
cell	NULL
death	NULL
are	NULL
exactly	NULL
equivalent	NULL
to	NULL
those	NULL
found	NULL
in	NULL
the	NULL
experiments	NULL
of	NULL
inhibition	NULL
of	NULL
CHMC	NULL
proliferation	NULL
:	NULL
maximal	NULL
prevention	NULL
with	NULL
9-cRA	NULL
requires	NULL
a	NULL
1000	NULL
fold	NULL
lower	NULL
concentration	NULL
than	NULL
that	NULL
required	NULL
with	NULL
tRA	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Recently	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
apoptotic	NULL
signal	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
on	NULL
CHMC	NULL
(	NULL
Ishikawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
is	NULL
blocked	NULL
by	NULL
tRA	NULL
inhibiting	NULL
both	NULL
c-Jun	NULL
NH	NULL
»	NULL
-terminal	NULL
kinase	NULL
and	NULL
activating	NULL
protein-1	NULL
expression	NULL
(	NULL
Moreno	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
19992	NULL
)	NULL
.	NULL

This	NULL
is	NULL
the	NULL
most	NULL
likely	NULL
mechanism	NULL
involved	NULL
in	NULL
the	NULL
preventive	NULL
effect	NULL
of	NULL
retinoids	NULL
against	NULL
H	NULL
,	NULL
O	NULL
;	NULL
-induced	NULL
cell	NULL
death	NULL
since	NULL
our	NULL
results	NULL
(	NULL
see	NULL
Figure	NULL
3B	NULL
and	NULL
Results	NULL
section	NULL
)	NULL
exclude	NULL
any	NULL
role	NULL
of	NULL
antioxidant	NULL
defences	NULL
.	NULL

9-cRA	NULL
also	NULL
inhibited	NULL
monocyte	NULL
adhesion	NULL
to	NULL
FCS-stimulated	NULL
CHMC	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
adhesion	NULL
molecules	NULL
revealed	NULL
that	NULL
9-cRA	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
FN	NULL
and	NULL
OP	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
but	NULL
not	NULL
VCAM-1	NULL
and	NULL
ICAM-1	NULL
expression	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
retinoid	NULL
on	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
FN	NULL
and	NULL
OP	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
is	NULL
an	NULL
effect	NULL
likely	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
respective	NULL
proteins	NULL
.	NULL

Although	NULL
VCAM-1	NULL
,	NULL
ICAM-1	NULL
,	NULL
FN	NULL
and	NULL
OP	NULL
are	NULL
involved	NULL
in	NULL
monocyte	NULL
adhesion	NULL
to	NULL
mesangial	NULL
cells	NULL
(	NULL
Chana	NULL
&	NULL
Wheeler	NULL
,	NULL
1999	NULL
;	NULL
Nagasaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Denton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Khachigian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
it	NULL
is	NULL
worthy	NULL
of	NULL
remark	NULL
that	NULL
increased	NULL
monocyte	NULL
adhesion	NULL
does	NULL
not	NULL
necessarily	NULL
correlate	NULL
to	NULL
increased	NULL
VCAM-1	NULL
or	NULL
ICAM-1	NULL
expression	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
in	NULL
the	NULL
model	NULL
of	NULL
low-density	NULL
lipoprotein-stimulated	NULL
monocyte	NULL
adhesion	NULL
to	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells-characterized	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
VCAM-1	NULL
,	NULL
ICAM-1	NULL
and	NULL
FN-monocyte	NULL
adhesion	NULL
is	NULL
inhibited	NULL
by	NULL
treatment	NULL
of	NULL
CHMC	NULL
with	NULL
the	NULL
antibody	NULL
anti-fibronectin	NULL
but	NULL
not	NULL
with	NULL
antibodies	NULL
anti-VCAM-1	NULL
or	NULL
anti-ICAM-1	NULL
(	NULL
Chana	NULL
&	NULL
Wheeler	NULL
,	NULL
1999	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
way	NULL
,	NULL
monocyte	NULL
entry	NULL
in	NULL
human	NULL
atherosclerotic	NULL
lesions	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
endothelial	NULL
areas	NULL
of	NULL
increased	NULL
VCAM-1	NULL
expression	NULL
but	NULL
with	NULL
increased	NULL
expression	NULL
of	NULL
connecting	NULL
segment-1	NULL
of	NULL
FN	NULL
(	NULL
Shih	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
may	NULL
be	NULL
speculated	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
FN	NULL
and	NULL
OP	NULL
might	NULL
be	NULL
sufficient	NULL
to	NULL
explain	NULL
the	NULL
retinoid-induced	NULL
inhibition	NULL
of	NULL
monocyte	NULL
adhesion	NULL
to	NULL
CHMC	NULL
.	NULL

However	NULL
,	NULL
specific	NULL
studies	NULL
must	NULL
be	NULL
undertaken	NULL
to	NULL
confirm	NULL
this	NULL
point	NULL
.	NULL

Retinoids	NULL
are	NULL
known	NULL
to	NULL
exert	NULL
their	NULL
biological	NULL
effects	NULL
by	NULL
binding	NULL
to	NULL
specific	NULL
nuclear	NULL
receptors	NULL
.	NULL

Each	NULL
subtype	NULL
of	NULL
nuclear	NULL
retinoid	NULL
receptors	NULL
is	NULL
thought	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
distinct	NULL
genes	NULL
because	NULL
the	NULL
subtypes	NULL
exhibit	NULL
specific	NULL
patterns	NULL
of	NULL
expression	NULL
during	NULL
embryonal	NULL
development	NULL
and	NULL
different	NULL
distribution	NULL
in	NULL
adult	NULL
tissues	NULL
(	NULL
Giguere	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Therefore	NULL
we	NULL
characterized	NULL
the	NULL
RAR/RXR	NULL
mRNA	NULL
expression	NULL
pattern	NULL
in	NULL
CHMC	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Several	NULL
interesting	NULL
observations	NULL
evolved	NULL
from	NULL
this	NULL
characterization	NULL
.	NULL

First	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
all	NULL
three	NULL
RARs	NULL
and	NULL
all	NULL
three	NULL
RXRs	NULL
,	NULL
implies	NULL
that	NULL
mesangial	NULL
cells	NULL
can	NULL
respond	NULL
to	NULL
exogenously	NULL
administered	NULL
retinoids	NULL
in	NULL
a	NULL
receptor-mediated	NULL
manner	NULL
.	NULL

Taking	NULL
into	NULL
account	NULL
that	NULL
endogenous	NULL
ligand	NULL
activity	NULL
of	NULL
9-cRA	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
kidney	NULL
(	NULL
Heyman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
RARs	NULL
and	NULL
RXRs	NULL
in	NULL
mesangial	NULL
cells	NULL
suggests	NULL
that	NULL
these	NULL
receptors	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
controlling	NULL
mesangial-specific	NULL
gene	NULL
expression	NULL
and	NULL
mesangial	NULL
cell	NULL
phenotype	NULL
in	NULL
vivo	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
data	NULL
showing	NULL
that	NULL
CHMC	NULL
are	NULL
highly	NULL
responsive	NULL
to	NULL
9-cRA	NULL
in	NULL
terms	NULL
of	NULL
modulation	NULL
of	NULL
RARs	NULL
and	NULL
RXRs	NULL
:	NULL
9-cRA	NULL
treatment	NULL
stimulated	NULL
expression	NULL
of	NULL
RAR-5	NULL
,	NULL
RAR-§	NULL
,	NULL
and	NULL
RXR-	NULL
«	NULL
genes	NULL
,	NULL
and	NULL
it	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
RXR-y	NULL
.	NULL

These	NULL
changes	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
9-cRA	NULL
.	NULL

Upon	NULL
binding	NULL
to	NULL
RARs	NULL
and	NULL
RXRs	NULL
,	NULL
retinoids	NULL
regulate	NULL
cellular	NULL
processes	NULL
by	NULL
directly	NULL
modulating	NULL
the	NULL
expression	NULL
of	NULL
responsive	NULL
genes	NULL
.	NULL

Therefore	NULL
the	NULL
changes	NULL
induced	NULL
by	NULL
9-cRA	NULL
on	NULL
mRNA	NULL
expression	NULL
of	NULL
the	NULL
RARs	NULL
and	NULL
RXRs	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
this	NULL
retinoid	NULL
on	NULL
CHMC	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
changes	NULL
in	NULL
RXRs	NULL
could	NULL
trigger	NULL
a	NULL
broad	NULL
spectrum	NULL
of	NULL
phenotypic	NULL
modifications	NULL
given	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
target	NULL
genes	NULL
by	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
,	NULL
including	NULL
RARs	NULL
,	NULL
VDR	NULL
(	NULL
vitamin	NULL
D	NULL
receptors	NULL
)	NULL
,	NULL
TR	NULL
(	NULL
thyroid	NULL
receptors	NULL
)	NULL
and	NULL
PPARs	NULL
(	NULL
peroxisome	NULL
proliferator	NULL
activated	NULL
receptors	NULL
)	NULL
,	NULL
usually	NULL
requires	NULL
prior	NULL
ligand-activated	NULL
nuclear	NULL
hormone	NULL
receptor	NULL
heterodimerization	NULL
with	NULL
RXRs	NULL
(	NULL
Giguere	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
emphasize	NULL
,	NULL
however	NULL
,	NULL
that	NULL
our	NULL
studies	NULL
have	NULL
not	NULL
assigned	NULL
a	NULL
retinoid	NULL
receptor-mediated	NULL
process	NULL
to	NULL
any	NULL
action	NULL
of	NULL
9-cRA	NULL
in	NULL
CHMC	NULL
.	NULL

Such	NULL
studies	NULL
will	NULL
require	NULL
dominant	NULL
negative	NULL
retinoid	NULL
receptors	NULL
,	NULL
synthetic	NULL
retinoids	NULL
that	NULL
specifically	NULL
activate	NULL
one	NULL
given	NULL
receptor	NULL
or	NULL
that	NULL
bind	NULL
specific	NULL
receptors	NULL
without	NULL
activating	NULL
them	NULL
,	NULL
or	NULL
the	NULL
cultivation	NULL
of	NULL
glomerular	NULL
mesangial	NULL
cells	NULL
from	NULL
knock-out	NULL
mice	NULL
deficient	NULL
in	NULL
specific	NULL
retinoid	NULL
receptors	NULL
.	NULL

The	NULL
glomerular	NULL
capillary	NULL
network	NULL
is	NULL
unique	NULL
in	NULL
that	NULL
circulating	NULL
phagocytes	NULL
may	NULL
potentially	NULL
adhere	NULL
to	NULL
both	NULL
endothelial	NULL
and	NULL
mesangial	NULL
cells	NULL
,	NULL
as	NULL
the	NULL
latter	NULL
may	NULL
be	NULL
found	NULL
interposed	NULL
between	NULL
endothelial	NULL
cells	NULL
(	NULL
Schena	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
9-cRA	NULL
inhibited	NULL
monocyte	NULL
adhesion	NULL
to	NULL
FCS-stimulated	NULL
CHMC	NULL
is	NULL
particularly	NULL
important	NULL
(	NULL
FCS	NULL
resembles	NULL
an	NULL
inflammatory	NULL
situation	NULL
,	NULL
given	NULL
that	NULL
it	NULL
contains	NULL
a	NULL
high	NULL
number	NULL
of	NULL
active	NULL
factors	NULL
present	NULL
during	NULL
inflammation	NULL
)	NULL
taking	NULL
into	NULL
account	NULL
that	NULL
monocytes	NULL
can	NULL
be	NULL
considered	NULL
as	NULL
the	NULL
real	NULL
effectors	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
glomerular	NULL
diseases	NULL
(	NULL
Schena	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
same	NULL
applies	NULL
to	NULL
the	NULL
prevention	NULL
of	NULL
mesangial	NULL
cell	NULL
death	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-	NULL
that	NULL
may	NULL
be	NULL
released	NULL
from	NULL
activated	NULL
monocytes/macrophages	NULL
(	NULL
Schena	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
-and	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
FCS-induced	NULL
mesangial	NULL
cell	NULL
proliferation	NULL
.	NULL

The	NULL
potential	NULL
of	NULL
9-cRA	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
inflammatory	NULL
glomerular	NULL
diseases	NULL
is	NULL
even	NULL
more	NULL
evident	NULL
if	NULL
we	NULL
take	NULL
into	NULL
account	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
9-cRA	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
is	NULL
comparable	NULL
to	NULL
the	NULL
blood	NULL
levels	NULL
found	NULL
in	NULL
cancer	NULL
patients	NULL
receiving	NULL
this	NULL
retinoid	NULL
(	NULL
Rizvi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
relevance	NULL
of	NULL
the	NULL
findings	NULL
presented	NULL
here	NULL
needs	NULL
to	NULL
be	NULL
confirmed	NULL
by	NULL
in	NULL
vivo	NULL
studies	NULL
in	NULL
animal	NULL
models	NULL
of	NULL
glomerulonephritis	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
SAF99-0085	NULL
from	NULL
the	NULL
Spanish	NULL
Comision	NULL
Interministerial	NULL
de	NULL
Ciencia	NULL
y	NULL
Tecnologia	NULL
and	NULL
08.06/0014/	NULL
99	NULL
from	NULL
the	NULL
Comunidad	NULL
de	NULL
Madrid	NULL
.	NULL

V.	NULL
Moreno	NULL
Manzano	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Comunidad	NULL
de	NULL
Madrid	NULL
.	NULL

Juan	NULL
Carlos	NULL
Sepulveda	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
of	NULL
the	NULL
Spanish	NULL
Ministerio	NULL
de	NULL
Educacion	NULL
,	NULL
Cultura	NULL
y	NULL
Deportes	NULL
.	NULL

We	NULL
gratefully	NULL
acknowledge	NULL
Ana	NULL
Morales	NULL
Entrena	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
Productos	NULL
Roche	NULL
S.A.	NULL
for	NULL
providing	NULL
the	NULL
retinoids	NULL
and	NULL
to	NULL
Dr	NULL
P.	NULL
Chambon	NULL
for	NULL
providing	NULL
the	NULL
RARs	NULL
and	NULL
RXRs	NULL
probes	NULL
,	NULL
to	NULL
Dr	NULL
Mushtaq	NULL
Ahmad	NULL
for	NULL
providing	NULL
the	NULL
VCAM-1	NULL
cDNA	NULL
probe	NULL
,	NULL
to	NULL
Dr	NULL
C.M	NULL
.	NULL

Giachelli	NULL
for	NULL
providing	NULL
the	NULL
OP	NULL
cDNA	NULL
probe	NULL
and	NULL
to	NULL
Dr	NULL
Jennifer	NULL
Laird	NULL
for	NULL
careful	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
1682	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
References	NULL
AEBI	NULL
,	NULL
H.E	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

Catalase	NULL
.	NULL

In	NULL
Methods	NULL
of	NULL
Enzymatic	NULL
Analysis	NULL
vol	NULL
III	NULL
.	NULL

Enzymes	NULL
I	NULL
:	NULL
Oxidoreductases	NULL
,	NULL
transferases	NULL
.	NULL

ed	NULL
.	NULL

Bergmeyer	NULL
H.U	NULL
.	NULL

pp	NULL
.	NULL

273-285	NULL
.	NULL

Basel	NULL
:	NULL
Verlag-Chemie	NULL
.	NULL

ALLENBY	NULL
,	NULL
G.	NULL
,	NULL
JANOCHA	NULL
,	NULL
R.	NULL
,	NULL
KAZMER	NULL
,	NULL
$	NULL
.	NULL

,	NULL
SPECK	NULL
,	NULL
J.	NULL
,	NULL
GRIPPO	NULL
,	NULL
J.F	NULL
.	NULL

&	NULL
LEVIN	NULL
,	NULL
A.A.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
9-cis-retinoic	NULL
acid	NULL
and	NULL
all-trans-retinoic	NULL
acid	NULL
to	NULL
retinoic	NULL
acid	NULL
receptors	NULL
«	NULL
,	NULL
$	NULL
and	NULL
y.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
16689-16695	NULL
.	NULL

BERG	NULL
,	NULL
W.J	NULL
.	NULL

,	NULL
NANUS	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
LEUNG	NULL
,	NULL
A.	NULL
,	NULL
BROWN	NULL
,	NULL
K.T	NULL
.	NULL

,	NULL
HUTCHINSON	NULL
,	NULL
B.	NULL
,	NULL
MAZUMDAR	NULL
,	NULL
M.	NULL
,	NULL
XU	NULL
,	NULL
X.	NULL
,	NULL
LOTAN	NULL
,	NULL
R.	NULL
,	NULL
REUTER	NULL
,	NULL
V.E	NULL
.	NULL

&	NULL
MOTZER	NULL
,	NULL
R.J.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Up-regulation	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
$	NULL
expression	NULL
in	NULL
renal	NULL
cancers	NULL
in	NULL
vivo	NULL
correlates	NULL
with	NULL
reponse	NULL
to	NULL
13-cis-retinoic	NULL
acid	NULL
and	NULL
interferon-a-2a	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
5	NULL
,	NULL
1671	NULL
1675	NULL
.	NULL

BRAND	NULL
,	NULL
N.	NULL
,	NULL
PETKOVICH	NULL
,	NULL
M.	NULL
,	NULL
KRUST	NULL
,	NULL
A.	NULL
,	NULL
CHAMBON	NULL
,	NULL
P.	NULL
,	NULL
DE	NULL
THE	NULL
,	NULL
H.	NULL
,	NULL
MARCHIO	NULL
,	NULL
A.	NULL
,	NULL
TIOLLAIS	NULL
,	NULL
P.	NULL
&	NULL
DEJEAN	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
second	NULL
human	NULL
retinoic	NULL
acid	NULL
receptor	NULL
.	NULL

Nature	NULL
,	NULL
332	NULL
,	NULL
850-853	NULL
.	NULL

BUTTKE	NULL
,	NULL
T.M	NULL
&	NULL
SANDSTROM	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Oxidative	NULL
stress	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
apoptosis	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
15	NULL
,	NULL
7-10	NULL
.	NULL

CHANA	NULL
,	NULL
RS	NULL
.	NULL

&	NULL
WHEELER	NULL
,	NULL
D.C.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Fibronectin	NULL
augments	NULL
monocyte	NULL
adhesion	NULL
to	NULL
low-density	NULL
lipoprotein-stimulated	NULL
mesangial	NULL
cells	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
55	NULL
,	NULL
179-188	NULL
.	NULL

CHOMCZYNSKI	NULL
,	NULL
P.	NULL
&	NULL
SACCHI	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
guanidinium	NULL
thiocyanate-pheno-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
162	NULL
,	NULL
156-159	NULL
.	NULL

DE	NULL
THE	NULL
,	NULL
H.	NULL
,	NULL
MARCHIO	NULL
,	NULL
A.	NULL
,	NULL
TIOLLAIS	NULL
,	NULL
P.	NULL
&	NULL
DEJEAN	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Differential	NULL
expression	NULL
and	NULL
ligand	NULL
regulation	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
«	NULL
and	NULL
B	NULL
genes	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
429-433	NULL
.	NULL

DENTON	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
MARSDEN	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
LUSCINSKAS	NULL
,	NULL
F.W	NULL
.	NULL

,	NULL
BRENNER	NULL
,	NULL
B.M	NULL
.	NULL

&	NULL
BRADY	NULL
,	NULL
HR	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Cytokine-induced	NULL
phagocyte	NULL
adhesion	NULL
to	NULL
human	NULL
mesangial	NULL
cells	NULL
:	NULL
role	NULL
of	NULL
CD11/CD18	NULL
integrins	NULL
and	NULL
ICAM-1	NULL
.	NULL

4m	NULL
.	NULL

J	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
261	NULL
,	NULL
F1071-F1079	NULL
.	NULL

DIEZ	NULL
,	NULL
ML	NULL
.	NULL

,	NULL
GARCIA-ESCRIBANO	NULL
,	NULL
C.	NULL
,	NULL
MEDINA	NULL
,	NULL
J.	NULL
,	NULL
BOYANO	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
ARILLA	NULL
,	NULL
E.	NULL
,	NULL
TORRECILLA	NULL
,	NULL
G.	NULL
,	NULL
RODRIGUEZ	NULL
,	NULL
D.	NULL
&	NULL
RODRIGUEZ	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
somatostatin	NULL
on	NULL
cultured	NULL
human	NULL
mesangial	NULL
cells	NULL
,	NULL
Endocrinology	NULL
,	NULL
136	NULL
,	NULL
3444-3451	NULL
.	NULL

GIACHELLI	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
BAE	NULL
,	NULL
N.	NULL
,	NULL
LOMBARDI	NULL
,	NULL
D.	NULL
,	NULL
MAJESKY	NULL
,	NULL
M.	NULL
&	NULL
SCHWARTZ	NULL
,	NULL
S.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
2B7	NULL
,	NULL
a	NULL
rat	NULL
mRNA	NULL
which	NULL
distinguishes	NULL
smooth	NULL
muscle	NULL
phenotypes	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
identical	NULL
to	NULL
osteopontin	NULL
(	NULL
secreted	NULL
phosphoprotein	NULL
I	NULL
,	NULL
2aR	NULL
)	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
177	NULL
,	NULL
867-873	NULL
.	NULL

GIACHELLI	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
SCHWARTZ	NULL
,	NULL
$	NULL
.M	NULL
.	NULL

&	NULL
LIAW	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Molecular	NULL
and	NULL
cellular	NULL
biology	NULL
of	NULL
osteopontin	NULL
:	NULL
Potential	NULL
role	NULL
in	NULL
cardiovascular	NULL
disease	NULL
.	NULL

Trends	NULL
Cardiovasc	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
5	NULL
,	NULL
88-95	NULL
.	NULL

GIGUERE	NULL
,	NULL
V.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Retinoic	NULL
acid	NULL
receptors	NULL
and	NULL
cellular	NULL
retinoid	NULL
binding	NULL
proteins	NULL
:	NULL
Complex	NULL
interplay	NULL
in	NULL
retinoid	NULL
signaling	NULL
.	NULL

Endocrine	NULL
Rev	NULL
.	NULL

,	NULL
15	NULL
,	NULL
61-79	NULL
.	NULL

GIGUERE	NULL
,	NULL
v.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Orphan	NULL
nuclear	NULL
receptors	NULL
:	NULL
from	NULL
gene	NULL
to	NULL
function	NULL
.	NULL

Endocrine	NULL
Rev	NULL
.	NULL

,	NULL
20	NULL
,	NULL
689-725	NULL
.	NULL

GRIFFITH	NULL
,	NULL
U.W	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
,	NULL
metabolism	NULL
and	NULL
toxicity	NULL
of	NULL
buthionine	NULL
sulfoximine	NULL
and	NULL
its	NULL
higher	NULL
homologs	NULL
,	NULL
potent	NULL
inhibitors	NULL
of	NULL
glutathione	NULL
synthesis	NULL
.	NULL

J.	NULL
Bio/	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
257	NULL
,	NULL
13704-13712	NULL
.	NULL

HEIN	NULL
,	NULL
T.W	NULL
.	NULL

&	NULL
KUO	NULL
,	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

LDL	NULL
impair	NULL
vasomotor	NULL
function	NULL
of	NULL
the	NULL
coronary	NULL
microcirculation	NULL
:	NULL
role	NULL
of	NULL
superoxide	NULL
anions	NULL
.	NULL

Circ	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
83	NULL
,	NULL
404-414	NULL
.	NULL

HEINDENREICH	NULL
,	NULL
$	NULL
.	NULL

,	NULL
SCHMIDT	NULL
,	NULL
M.	NULL
,	NULL
BACHMANN	NULL
,	NULL
J	NULL
.	NULL

&	NULL
HARRACH	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Apoptosis	NULL
of	NULL
monocytes	NULL
cultured	NULL
from	NULL
long-term	NULL
hemodialysis	NULL
patients	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
49	NULL
,	NULL
792-799	NULL
.	NULL

HEYMAN	NULL
,	NULL
R.A.	NULL
,	NULL
MANGELSDORF	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
DYCK	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
STEIN	NULL
,	NULL
R.B	NULL
.	NULL

,	NULL
EICHELE	NULL
,	NULL
G.	NULL
,	NULL
EVANS	NULL
,	NULL
R.M	NULL
.	NULL

&	NULL
THALLER	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

9-cis	NULL
retinoic	NULL
acid	NULL
is	NULL
a	NULL
high	NULL
affinity	NULL
ligand	NULL
for	NULL
the	NULL
retinoid	NULL
X	NULL
receptor	NULL
.	NULL

Cell	NULL
,	NULL
68	NULL
,	NULL
397-406	NULL
.	NULL

HISSIN	NULL
,	NULL
P.J	NULL
.	NULL

&	NULL
HILF	NULL
,	NULL
R.	NULL
(	NULL
1976	NULL
)	NULL
.	NULL

A	NULL
fluorimetric	NULL
method	NULL
for	NULL
determination	NULL
of	NULL
oxidized	NULL
and	NULL
reduced	NULL
glutathione	NULL
in	NULL
tissues	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
74	NULL
,	NULL
214-226	NULL
.	NULL

HOFFMAN	NULL
,	NULL
A.D.	NULL
,	NULL
ENGELSTEIN	NULL
,	NULL
D.	NULL
,	NULL
BOGENRIEDER	NULL
,	NULL
T	NULL
,	NULL
PAPAN	NULL
:	NULL
-DREOU	NULL
,	NULL
C.N	NULL
.	NULL

,	NULL
STECKELMAN	NULL
,	NULL
E.	NULL
,	NULL
DAVE	NULL
,	NULL
A.	NULL
,	NULL
MOTZER	NULL
,	NULL
RJ	NULL
.	NULL

,	NULL
DMITROVSKY	NULL
,	NULL
E.	NULL
,	NULL
ALBINO	NULL
,	NULL
A..P.	NULL
&	NULL
NANUS	NULL
,	NULL
D.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
B	NULL
in	NULL
human	NULL
renal	NULL
cell	NULL
carcinomas	NULL
correlates	NULL
with	NULL
sensitivity	NULL
to	NULL
the	NULL
antiproliferative	NULL
effects	NULL
of	NULL
13-cis-retinoic	NULL
acid	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1077-1082	NULL
.	NULL

HUANG	NULL
,	NULL
H.F.	NULL
$	NULL
.	NULL

,	NULL
LI	NULL
,	NULL
M.T	NULL
.	NULL

,	NULL
VON	NULL
HAGEN	NULL
,	NULL
$	NULL
.	NULL

,	NULL
ZHANG	NULL
,	NULL
Y.F	NULL
.	NULL

&	NULL
IRWIN	NULL
,	NULL
R.J.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Androgen	NULL
modulation	NULL
of	NULL
the	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
of	NULL
retinoic	NULL
acid	NULL
receptors	NULL
in	NULL
the	NULL
prostate	NULL
,	NULL
seminal	NULL
vesicles	NULL
and	NULL
kidney	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Endocrinology	NULL
,	NULL
138	NULL
,	NULL
553-559	NULL
.	NULL

ISHIKAWA	NULL
,	NULL
Y.	NULL
,	NULL
YOKOO	NULL
,	NULL
T.	NULL
&	NULL
KITAMURA	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

c-jun/AP-1	NULL
,	NULL
but	NULL
not	NULL
NF-xB	NULL
,	NULL
is	NULL
a	NULL
mediator	NULL
for	NULL
oxidant	NULL
initiated	NULL
apoptosis	NULL
in	NULL
glomerular	NULL
mesangial	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
240	NULL
,	NULL
496-501	NULL
.	NULL

KASHGARIAN	NULL
,	NULL
M.	NULL
&	NULL
STERZEL	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
pathobiology	NULL
of	NULL
the	NULL
mesangium	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
41	NULL
,	NULL
524-529	NULL
.	NULL

KHACHIGIAN	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
COLLINS	NULL
,	NULL
T.	NULL
&	NULL
FRIES	NULL
,	NULL
J.W.U	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

N-Acetylcysteine	NULL
blocks	NULL
mesangial	NULL
VCAM-1	NULL
and	NULL
NF-xB	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

4m	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
151	NULL
,	NULL
1225-1229	NULL
.	NULL

KOSMEHL	NULL
,	NULL
H.	NULL
,	NULL
BERNDT	NULL
,	NULL
A	NULL
.	NULL

&	NULL
KATENKAMP	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Molecular	NULL
variants	NULL
of	NULL
fibronectin	NULL
and	NULL
laminin	NULL
:	NULL
structure	NULL
,	NULL
physiological	NULL
occurrence	NULL
and	NULL
histopathological	NULL
aspects	NULL
.	NULL

Virchows	NULL
Arch	NULL
.	NULL

4	NULL
Pathol	NULL
.	NULL

Anat	NULL
.	NULL

Histopathol	NULL
.	NULL

,	NULL
429	NULL
,	NULL
311-322	NULL
.	NULL

KRUST	NULL
,	NULL
A.	NULL
,	NULL
KASTNER	NULL
,	NULL
P.	NULL
,	NULL
PETKOVICH	NULL
,	NULL
M.	NULL
,	NULL
ZELENT	NULL
,	NULL
A	NULL
.	NULL

&	NULL
CHAMBON	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
third	NULL
human	NULL
retinoic	NULL
acid	NULL
receptor	NULL
,	NULL
hRAR-y	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
,	NULL
86	NULL
,	NULL
5310-5314	NULL
.	NULL

LADEMARCO	NULL
,	NULL
MF	NULL
.	NULL

,	NULL
BARKS	NULL
,	NULL
J.L	NULL
.	NULL

&	NULL
DEAN	NULL
,	NULL
D.C.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
expression	NULL
by	NULL
IL-4	NULL
and	NULL
TNF-	NULL
«	NULL
in	NULL
cultured	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
C/in	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
95	NULL
,	NULL
264-271	NULL
.	NULL

LAN	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
YU	NULL
,	NULL
X.Q	NULL
.	NULL

,	NULL
YANG	NULL
,	NULL
N.	NULL
,	NULL
NIKOLIC-PATERSON	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
MU	NULL
,	NULL
W.	NULL
,	NULL
PICHLER	NULL
,	NULL
R.	NULL
,	NULL
JOHNSON	NULL
,	NULL
R.J.	NULL
&	NULL
ATKINS	NULL
,	NULL
R.C	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

De	NULL
novo	NULL
glomerular	NULL
osteopontin	NULL
expression	NULL
in	NULL
rat	NULL
crescentic	NULL
glomerulonephritis	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
53	NULL
,	NULL
136-145	NULL
.	NULL

LEID	NULL
,	NULL
M.	NULL
,	NULL
KASTNER	NULL
,	NULL
P.	NULL
,	NULL
LYONS	NULL
,	NULL
R.	NULL
,	NULL
NAKSHARTI	NULL
,	NULL
H.	NULL
,	NULL
SAUNDERS	NULL
,	NULL
M.	NULL
,	NULL
ZACHAREWSKI	NULL
,	NULL
T.	NULL
,	NULL
CHEN	NULL
,	NULL
J.	NULL
,	NULL
STAUB	NULL
,	NULL
A.	NULL
,	NULL
GARNIER	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
MADER	NULL
,	NULL
$	NULL
.	NULL

&	NULL
CHAMBON	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Purification	NULL
,	NULL
cloning	NULL
and	NULL
RXR	NULL
identity	NULL
of	NULL
the	NULL
HeLa	NULL
cell	NULL
factor	NULL
with	NULL
which	NULL
RAR	NULL
or	NULL
TR	NULL
heterodimerizes	NULL
to	NULL
bind	NULL
target	NULL
sequences	NULL
efficiently	NULL
.	NULL

Cell	NULL
,	NULL
68	NULL
,	NULL
377-395	NULL
.	NULL

LEVIN	NULL
,	NULL
A.A.	NULL
,	NULL
STURZENBECKER	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
KAZMER	NULL
,	NULL
$	NULL
.	NULL

,	NULL
BASOKOWSKI	NULL
,	NULL
T.	NULL
,	NULL
HUSELTON	NULL
,	NULL
C.	NULL
,	NULL
ALLENBY	NULL
,	NULL
G.	NULL
,	NULL
SPECK	NULL
,	NULL
J.	NULL
,	NULL
KRATZEISEN	NULL
,	NULL
C.	NULL
,	NULL
ROSENBERG	NULL
,	NULL
M.	NULL
,	NULL
LOVEY	NULL
,	NULL
A	NULL
.	NULL

&	NULL
GRIPPO	NULL
,	NULL
J.F	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

9-cis	NULL
retinoic	NULL
acid	NULL
stereoisomer	NULL
binds	NULL
and	NULL
activates	NULL
the	NULL
nuclear	NULL
receptor	NULL
RXR	NULL
«	NULL
.	NULL

Nature	NULL
,	NULL
355	NULL
,	NULL
359-361	NULL
.	NULL

LEVIN	NULL
,	NULL
M.S	NULL
.	NULL

&	NULL
DAVIS	NULL
,	NULL
A.E	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Retinoic	NULL
acid	NULL
increases	NULL
cellular	NULL
retinol	NULL
binding	NULL
protein	NULL
II	NULL
mRNA	NULL
and	NULL
retinol	NULL
uptake	NULL
in	NULL
the	NULL
human	NULL
intestinal	NULL
Caco-2	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
.	NULL

Nutr	NULL
.	NULL

,	NULL
127	NULL
,	NULL
13-17	NULL
.	NULL

LOVAT	NULL
,	NULL
P.E	NULL
.	NULL

,	NULL
IRVING	NULL
,	NULL
H.	NULL
,	NULL
ANNICCHIARICO-PETRUZZELLI	NULL
,	NULL
M.	NULL
,	NULL
BERNASSOLA	NULL
,	NULL
F.	NULL
,	NULL
MALCOM	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
PEARSON	NULL
,	NULL
A.D.	NULL
,	NULL
MELINO	NULL
,	NULL
G.	NULL
&	NULL
REDFERN	NULL
,	NULL
C.P	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Retinoids	NULL
in	NULL
neuroblastoma	NULL
therapy	NULL
:	NULL
distinct	NULL
biological	NULL
properties	NULL
of	NULL
9-cis-	NULL
and	NULL
all-trans-retinoic	NULL
acid	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
33	NULL
,	NULL
2075-2080	NULL
.	NULL

LOWRY	NULL
,	NULL
O.H	NULL
.	NULL

,	NULL
ROSEBROUGH	NULL
,	NULL
KF	NULL
.	NULL

,	NULL
FARR	NULL
,	NULL
A.G.	NULL
,	NULL
RANDALL	NULL
,	NULL
RJ	NULL
.	NULL

(	NULL
1951	NULL
)	NULL
.	NULL

Protein	NULL
measurement	NULL
with	NULL
the	NULL
Folin	NULL
phenol	NULL
reagent	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
19	NULL
,	NULL
265-275	NULL
.	NULL

MCGAHON	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
MARTIN	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
BISSONNETTE	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
MAHBOUBI	NULL
,	NULL
A.	NULL
,	NULL
SHI	NULL
,	NULL
Y.	NULL
,	NULL
MOGIL	NULL
,	NULL
R.J.	NULL
,	NULL
NISHIOKA	NULL
,	NULL
W.K	NULL
.	NULL

&	NULL
GREEN	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
end	NULL
of	NULL
the	NULL
(	NULL
cell	NULL
)	NULL
line	NULL
:	NULL
Methods	NULL
for	NULL
the	NULL
study	NULL
of	NULL
apoptosis	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
Methods	NULL
in	NULL
Cell	NULL
Biology	NULL
:	NULL
Vol	NULL
46	NULL
.	NULL

Cell	NULL
Death	NULL
.	NULL

ed	NULL
.	NULL

Schwartz	NULL
,	NULL
L.M	NULL
.	NULL

and	NULL
Osborne	NULL
,	NULL
B.A	NULL
.	NULL

pp	NULL
.	NULL

153-187	NULL
,	NULL
New	NULL
York	NULL
:	NULL
Academic	NULL
Press	NULL
.	NULL

MEYERS	NULL
,	NULL
J.C.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
type	NULL
I	NULL
collagen	NULL
and	NULL
cellular	NULL
fibronectin	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
43	NULL
,	NULL
45-52	NULL
.	NULL

MORENO	NULL
,	NULL
V	NULL
,	NULL
ISHIKAWA	NULL
,	NULL
Y.	NULL
,	NULL
LUCIO	NULL
,	NULL
F.J.	NULL
&	NULL
KITAMURA	NULL
,	NULL
M.	NULL
(	NULL
19992	NULL
)	NULL
.	NULL

Suppression	NULL
of	NULL
apoptosis	NULL
by	NULL
all-trans-retinoic	NULL
acid	NULL
:	NULL
dual	NULL
intervention	NULL
via	NULL
inhibition	NULL
of	NULL
c-Jun	NULL
NH-terminal	NULL
kinase	NULL
and	NULL
AP-1	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
274	NULL
,	NULL
20251-20258	NULL
.	NULL

MORENO	NULL
,	NULL
V.	NULL
,	NULL
RODRIGUEZ	NULL
,	NULL
M.	NULL
,	NULL
RODRIGUEZ	NULL
,	NULL
D.	NULL
&	NULL
LUCIO	NULL
,	NULL
FJ	NULL
.	NULL

(	NULL
1999b	NULL
)	NULL
.	NULL

Tretinoin	NULL
prevents	NULL
age-related	NULL
renal	NULL
changes	NULL
and	NULL
stimulates	NULL
antioxidant	NULL
defenses	NULL
in	NULL
cultured	NULL
renal	NULL
mesangial	NULL
cells	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

,	NULL
289	NULL
,	NULL
123-132	NULL
.	NULL

NAGASAKI	NULL
,	NULL
T.	NULL
,	NULL
ISHIMURA	NULL
,	NULL
E.	NULL
,	NULL
SHIOI	NULL
,	NULL
A.	NULL
,	NULL
JONO	NULL
,	NULL
$	NULL
.	NULL

,	NULL
INABA	NULL
,	NULL
M.	NULL
,	NULL
NISHIZAWA	NULL
,	NULL
Y.	NULL
,	NULL
MORII	NULL
,	NULL
H.	NULL
&	NULL
OTANI	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Osteopontin	NULL
gene	NULL
expression	NULL
and	NULL
protein	NULL
synthesis	NULL
in	NULL
cultured	NULL
rat	NULL
mesangial	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
233	NULL
,	NULL
81-85	NULL
.	NULL

NATH	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
FISCHEREDER	NULL
,	NULL
M.	NULL
&	NULL
HOSTETTER	NULL
,	NULL
T.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
oxidants	NULL
in	NULL
progressive	NULL
renal	NULL
injury	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
45	NULL
(	NULL
Suppl	NULL
.	NULL

45	NULL
)	NULL
:	NULL
S111-S115	NULL
.	NULL

ORFANOS	NULL
,	NULL
C.E	NULL
.	NULL

,	NULL
ZOUBOULIS	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
ALMOND-ROESLER	NULL
,	NULL
B	NULL
.	NULL

&	NULL
GEILEN	NULL
,	NULL
C.C	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Current	NULL
use	NULL
and	NULL
future	NULL
potential	NULL
role	NULL
of	NULL
retinoids	NULL
in	NULL
dermatology	NULL
.	NULL

Drugs	NULL
,	NULL
53	NULL
,	NULL
358-388	NULL
.	NULL

OSBORN	NULL
,	NULL
L.	NULL
,	NULL
HESSION	NULL
,	NULL
C.	NULL
,	NULL
TIZARD	NULL
,	NULL
R.	NULL
,	NULL
VASSALLO	NULL
,	NULL
C.	NULL
,	NULL
LUHOWSK	NULL
YJ	NULL
,	NULL
$	NULL
.	NULL

,	NULL
CHI	NULL
,	NULL
R.G	NULL
.	NULL

&	NULL
LOBB	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Direct	NULL
expression	NULL
cloning	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
a	NULL
cytokine-induced	NULL
endothelial	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
,	NULL
52	NULL
,	NULL
1203-1211	NULL
.	NULL

British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL
V.	NULL
Moreno	NULL
Manzano	NULL
et	NULL
al	NULL
Mesangial	NULL
cells	NULL
are	NULL
a	NULL
target	NULL
for	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
1683	NULL
PASSLICK	NULL
,	NULL
B.	NULL
,	NULL
FLIEGER	NULL
,	NULL
D.	NULL
&	NULL
ZIEGLER-HEITBROCK	NULL
,	NULL
H.W	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
monocyte	NULL
sub-population	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
.	NULL

Blood	NULL
,	NULL
74	NULL
,	NULL
2527-2534	NULL
.	NULL

PETKOVICH	NULL
,	NULL
N.	NULL
,	NULL
BRAND	NULL
,	NULL
N.	NULL
,	NULL
KRUST	NULL
,	NULL
A	NULL
.	NULL

&	NULL
CHAMBON	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

A	NULL
human	NULL
retinoic	NULL
acid	NULL
receptor	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
family	NULL
of	NULL
nuclear	NULL
receptors	NULL
.	NULL

Nature	NULL
,	NULL
330	NULL
,	NULL
444-450	NULL
.	NULL

PFEILSCHIFTER	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Mesangial	NULL
cells	NULL
orchestrate	NULL
inflammation	NULL
in	NULL
the	NULL
renal	NULL
glomerulus	NULL
.	NULL

News	NULL
Physiol	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
9	NULL
,	NULL
271-276	NULL
.	NULL

PICK	NULL
,	NULL
E.	NULL
&	NULL
KEISARLI	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
.	NULL

A	NULL
simple	NULL
colorimetric	NULL
method	NULL
for	NULL
the	NULL
measurement	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
produced	NULL
by	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Meth	NULL
.	NULL

,	NULL
38	NULL
,	NULL
161-170	NULL
.	NULL

PIETERSMA	NULL
,	NULL
A.	NULL
,	NULL
TILLY	NULL
,	NULL
B.C	NULL
.	NULL

,	NULL
GAESTEL	NULL
,	NULL
M.	NULL
,	NULL
JONG	NULL
,	NULL
N.	NULL
,	NULL
LEE	NULL
,	NULL
J.C.	NULL
,	NULL
KORSTER	NULL
,	NULL
J.F	NULL
.	NULL

&	NULL
SLUITER	NULL
,	NULL
w.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

P38	NULL
mitogen	NULL
activated	NULL
protein	NULL
kinase	NULL
regulates	NULL
endothelial	NULL
VCAM-1	NULL
expression	NULL
at	NULL
the	NULL
post-transcriptional	NULL
level	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
230	NULL
,	NULL
44-48	NULL
.	NULL

RICARDO	NULL
,	NULL
$	NULL
.D	NULL
.	NULL

,	NULL
BERTRAM	NULL
,	NULL
J.F	NULL
.	NULL

&	NULL
RYAN	NULL
,	NULL
G.B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Reactive	NULL
oxygen	NULL
species	NULL
in	NULL
puromycin	NULL
aminonucleoside	NULL
nephrosis	NULL
:	NULL
In	NULL
vitro	NULL
studies	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
45	NULL
,	NULL
1057-1069	NULL
.	NULL

RIZVI	NULL
,	NULL
NA	NULL
.	NULL

,	NULL
MARSHALL	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
NESS	NULL
,	NULL
E.	NULL
,	NULL
YOE	NULL
,	NULL
J.	NULL
,	NULL
GILL	NULL
,	NULL
GM	NULL
.	NULL

,	NULL
TRUGLIA	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
LOEWEN	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
JAUNAKIS	NULL
,	NULL
D.	NULL
,	NULL
ULM	NULL
,	NULL
EH	NULL
.	NULL

&	NULL
HAWKINS	NULL
,	NULL
M.J.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Phase	NULL
I	NULL
study	NULL
of	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
ALRT1057	NULL
capsules	NULL
)	NULL
in	NULL
adults	NULL
with	NULL
advanced	NULL
cancer	NULL
.	NULL

C/in	NULL
.	NULL

Cancer	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
4	NULL
,	NULL
1437-1442	NULL
.	NULL

SCHENA	NULL
,	NULL
F.P	NULL
.	NULL

,	NULL
GESUALDO	NULL
,	NULL
L.	NULL
,	NULL
GRANDALIANO	NULL
,	NULL
G.	NULL
&	NULL
MONTINARO	NULL
,	NULL
v.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Progression	NULL
of	NULL
renal	NULL
damage	NULL
in	NULL
human	NULL
glomerulone-phritides	NULL
:	NULL
is	NULL
there	NULL
sleight	NULL
of	NULL
hand	NULL
in	NULL
winning	NULL
the	NULL
game	NULL
?	NULL

.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
52	NULL
,	NULL
1439-1457	NULL
.	NULL

SCHENA	NULL
,	NULL
F.P	NULL
.	NULL

,	NULL
MONTINARO	NULL
,	NULL
V.	NULL
&	NULL
GESUALDO	NULL
,	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Glomerular	NULL
mesangial	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

In	NULL
Immunopharmacology	NULL
of	NULL
the	NULL
Renal	NULL
System	NULL
.	NULL

ed	NULL
.	NULL

Tetta	NULL
,	NULL
C.	NULL
pp	NULL
.	NULL

49-86	NULL
.	NULL

London	NULL
:	NULL
Academic	NULL
Press	NULL
.	NULL

SHIH	NULL
,	NULL
P.T	NULL
.	NULL

,	NULL
ELICES	NULL
,	NULL
M.J.	NULL
,	NULL
FANG	NULL
,	NULL
Z.T	NULL
.	NULL

,	NULL
UGAROVA	NULL
,	NULL
TP	NULL
.	NULL

,	NULL
STRAHL	NULL
,	NULL
D.	NULL
,	NULL
TERRITO	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
FRANK	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
KOVACH	NULL
,	NULL
N.L	NULL
.	NULL

,	NULL
CABANAS	NULL
,	NULL
C.	NULL
,	NULL
BERLINER	NULL
,	NULL
J.A	NULL
.	NULL

&	NULL
VORA	NULL
,	NULL
D.K	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Minimally	NULL
modified	NULL
low-density	NULL
lipoproteins	NULL
induces	NULL
monocyte	NULL
adhesion	NULL
to	NULL
endothelial	NULL
connecting	NULL
segment-1	NULL
by	NULL
activating	NULL
Bl-integrin	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
103	NULL
,	NULL
613-625	NULL
.	NULL

SHIMIZU	NULL
,	NULL
A.	NULL
,	NULL
KITAMURA	NULL
,	NULL
H.	NULL
,	NULL
MASUDA	NULL
,	NULL
Y.	NULL
,	NULL
ISHIZAKI	NULL
,	NULL
M.	NULL
,	NULL
SUGISA-KI	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
YAMANAKA	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Apoptosis	NULL
in	NULL
the	NULL
repair	NULL
process	NULL
of	NULL
experimental	NULL
proliferative	NULL
glomerulonephritis	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

,	NULL
47	NULL
,	NULL
114-121	NULL
.	NULL

SIMONSON	NULL
,	NULL
M.S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Anti-AP-1	NULL
activity	NULL
of	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
in	NULL
glomerular	NULL
mesangial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
267	NULL
,	NULL
F805-F815	NULL
.	NULL

SPRINGER	NULL
,	NULL
T.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
,	NULL
301	NULL
314	NULL
.	NULL

STAUTON	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
DUSTIN	NULL
,	NULL
M.L	NULL
.	NULL

&	NULL
SPRINGER	NULL
,	NULL
T.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Functional	NULL
cloning	NULL
of	NULL
ICAM-2	NULL
,	NULL
a	NULL
cell	NULL
adhesion	NULL
ligand	NULL
for	NULL
LFA-1	NULL
homo-logous	NULL
to	NULL
ICAM-1	NULL
.	NULL

Nature	NULL
,	NULL
339	NULL
,	NULL
61-64	NULL
.	NULL

SUGAWARA	NULL
,	NULL
A.	NULL
,	NULL
SANNO	NULL
,	NULL
N.	NULL
,	NULL
TAKAHASHI	NULL
,	NULL
N.	NULL
,	NULL
OSAMURA	NULL
,	NULL
R.Y	NULL
.	NULL

&	NULL
ABE	NULL
,	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Retinoid	NULL
X	NULL
receptors	NULL
in	NULL
the	NULL
kidney	NULL
:	NULL
their	NULL
protein	NULL
expression	NULL
and	NULL
functional	NULL
significance	NULL
.	NULL

Endocrinology	NULL
,	NULL
138	NULL
,	NULL
3175-3180	NULL
.	NULL

WAN	NULL
,	NULL
H.	NULL
,	NULL
DAWSON	NULL
,	NULL
ML	NULL
,	NULL
HONG	NULL
,	NULL
W.K	NULL
.	NULL

&	NULL
LOTAN	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Overexpressed	NULL
activated	NULL
retinoid	NULL
X	NULL
receptors	NULL
can	NULL
mediate	NULL
inhibitory	NULL
effects	NULL
of	NULL
retinoids	NULL
in	NULL
human	NULL
carcinoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
26915-26922	NULL
.	NULL

YANG	NULL
,	NULL
T.	NULL
,	NULL
MICHELE	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
PARK	NULL
,	NULL
J.	NULL
,	NULL
SMART	NULL
,	NULL
A.M.	NULL
,	NULL
LIN	NULL
,	NULL
Z.	NULL
,	NULL
BROSIUS	NULL
III	NULL
,	NULL
F.C	NULL
.	NULL

,	NULL
SCHNERMANN	NULL
,	NULL
J.B.	NULL
&	NULL
BRIGGS	NULL
,	NULL
J.P.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
peroxisomal	NULL
proliferator-activated	NULL
receptors	NULL
and	NULL
retinoid	NULL
X	NULL
receptors	NULL
in	NULL
the	NULL
kidney	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
277	NULL
,	NULL
F966-F973	NULL
.	NULL

(	NULL
Received	NULL
July	NULL
7	NULL
,	NULL
2000	NULL
Revised	NULL
September	NULL
8	NULL
,	NULL
2000	NULL
Accepted	NULL
September	NULL
21	NULL
,	NULL
2000	NULL
)	NULL
British	NULL
Journal	NULL
of	NULL
Pharmacology	NULL
vol	NULL
131	NULL
(	NULL
8	NULL
)	NULL

